TW201006503A - Compositions and devices - Google Patents

Compositions and devices Download PDF

Info

Publication number
TW201006503A
TW201006503A TW098103769A TW98103769A TW201006503A TW 201006503 A TW201006503 A TW 201006503A TW 098103769 A TW098103769 A TW 098103769A TW 98103769 A TW98103769 A TW 98103769A TW 201006503 A TW201006503 A TW 201006503A
Authority
TW
Taiwan
Prior art keywords
acid
amino acid
composition
arginine
basic amino
Prior art date
Application number
TW098103769A
Other languages
Chinese (zh)
Other versions
TWI367763B (en
Inventor
Rajnish Kohli
Richard Scott Robinson
Michael Prencipe
Richard J Sullivan
Diane Cummins
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of TW201006503A publication Critical patent/TW201006503A/en
Application granted granted Critical
Publication of TWI367763B publication Critical patent/TWI367763B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
  • Brushes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The present invention provides oral instruments comprising a basic amino acid, to compositions for making such instruments, and to methods of making and using such instruments.

Description

201006503 六、發明說明: 此專利申請案主張擁有2008年2月8曰提出之美國專 利申請案序號61/027,428的權利,藉由引述將其内容併入 於此。 【發明所屬之技術領域】 本發明提供包含鹼性胺基酸的口腔器具及製造此類器 具的組成物,以及製造和使用此類器具的方法。 【先前技術】 已建議使用精胺酸和其他鹼性胺基酸於口腔保健以及 認為其在對抗鱗齒形成和牙齒敏感具有顯著效益。已認為 口腔内鹼性胺基酸被某些非生齲齒類型細菌例如血鏈球菌 (S· sanguis)所代謝,其將與口腔内牙齒的生齲齒菌例如變異 鏈球菌(S. mutans)產生競爭作用。精胺酸溶解菌能利用精胺 酸和其他鹼性胺基酸產生氨而提高環境pH,同時齲齒菌則 將糖代謝成乳酸而降低牙斑pH和使牙齒去礦化,最後造成 20 使用精胺酸處理口腔,目前係以牙粉(dentifrice)級 成物例如DenClude®來完成。亦建議以精胺酸配製成食物和 飲料產品。雖然經處理例如刷牙、咀嚼口香糖或吃富含料 胺酸食物之後精胺酸的有益效應可在口腔内持續數 數小時之久,但是較佳為發展可傳遞精胺酸至口腔的其^ 組成物和裝置,例如協同含精胺酸的組成物,或單獨。、 用於口腔的器具已為技術領域中所熟知及包括例如牙 3 201006503 刷到舌器牙線、牙籤、護口膠(mouth guard ),以及牙 齒矯正裝置例如牙套和固位器。此類器具雖然可被驗性胺 基酸所處理’但是該驗性胺基酸可能產生滲漏或侵触該器 具表面而需要費時地重複處理並且對使用者而言極不方 5 便。此類器具的處理亦可能極為複雜,並且不完全或不正 確的處理叮倉b導致過少或過多的驗性胺基酸被併入該器具 的表面。因此亟需創造可克服這些困難的組成物、裝置和 方法。 【發明内容】 10 本發明係關於能將鹼性胺基酸如精胺酸傳遞至口腔的 組成物及裝置其用於例如⑴減少或抑制蛀牙的形成;(⑴ 減少、修補或抑制早期琺瑯質病變,例如藉由定量光激發 螢光(QLF)或電齲齒測量法(ECM)的測定;(iii)減少或抑制 牙齒的去礦化及促進再礦化;(iv)減少牙齒過敏性;(v)減 15 少或抑制齒齦炎;〇i)促進口腔内潰瘍或傷口的癒合;(νϋ) 降低產酸菌的濃度;(viii)增加精胺酸溶解菌的相對濃度; (ix)抑制口腔内微生物生物膜的形成;使牙垢pH上升 及/或維持在至少pH 5.5的程度;(xi)減少牙垢的積聚;(xii) 清潔牙齒和口腔;(xiii)治療口腔乾燥;(xiv)改善身體健 20 康;及/或(xv)使牙齒變白。可單獨使用此類的組成物和裝 置或協同含其他驗性胺基酸的組成物如牙粉組成物以傳遞 驗性胺基酸至口腔。 本發明因此包含組成物1.0的一種包括喪入生物可姓 性(bioerodable)聚合物内之鹼性胺基酸的組成物。 201006503 本發明亦包括下列的組成物: 1.1組成物1.0其中該鹼性胺基酸係精胺酸、離胺酸、瓜胺 酸、鳥胺酸、肌酸、組胺酸、二胺基丁酸、二胺基丙 酸,其鹽及/或其組合。 5 m 10 15 _ 20 1·2組成物1·0或u其中該鹼性胺基酸具有L-構型。 1.3任何上述組成物其中該鹼性胺基酸係精胺酸。 1.4任何上述組成物其中該鹼性胺基酸係L-精胺酸。 1.5任何上述組成物包含鹽型的鹼性胺基酸。 1.6任何上述組成物包含精胺酸磷酸鹽。 1.7任何上述組成物包含精胺酸鹽酸鹽。 1.8任何上述組成物包含精胺酸硫酸鹽。 1.9任何上述組成物包含精胺酸碳酸氫鹽。 1.10任何上述組成物其中該生物可蝕性聚合物係選自聚 (乳酸)、聚(乙醇酸)和共聚物;聚二噚酮、聚(麩胺酸乙 醋)、聚(羥基丁酸酯)、聚(羥基戊酸酯)和共聚物;聚己 内酯、聚酸酐、聚(原酸酯)、聚(亞胺基碳酸酯)、聚酯 醯胺類、聚酯胺類、聚氰丙烯酸酯類、聚磷腈類,共 聚物及其他脂族聚酯,或其適當共聚物包括聚_L-乳酸 和聚ε -己内酿(e-caprolactone)的共聚物、金纖維蛋 白(fibrin )、膠原蛋白、葡萄胺聚醣 (glycosoaminoglycan)、寡醣、多醣、軟骨素、聚葡 萄胺糖(chitosan)、褐藻酸酯、纖維蛋白(fibring)、纖 維蛋白原、纖維素、澱粉、葡聚糖、糊精、玻尿酸、 肝素、彈性蛋白;多嵌段共聚物例如建構自乙交酯、 5 201006503 丙父自曰ε _己内酿的基礎單位;以及聚乙二醇和聚(酯 ,胺)聚合物或類似物’以白胺酸、笨丙胺酸及/或精 胺酸為基礎’選擇地具有一或多種二元醇類和一或多 種二甲酸類。 2何下文中組成物進一步包含存在於孔隙内的的氟化 孤,例如選自氟化亞錫、氟化鈉、氟化鉀、單氟磷酸 納氟石夕酸納、氟石夕酸銨、氧化胺、氟化敍,及其組 合。 ι〇 丨.12任^下文中組成物進一步包含抗菌劑選自三氣沙;草 1〇 本萃取物和精油(例如迷迭香萃取物、茶樹萃取物、木 蘭萃取物、瑞香酚、薄荷醇、桉葉酵、香葉醇、香芹 酚、擰檬醛、檜木醇、兒茶酚、曱基水揚酸、表沒食 子兒余素沒食子酸酯(epigallocatechin gallate)、表沒 食子兒茶素、沒食子酸、碧桃茉莉萃取物、沙棘 15 (sea'buckthorn)萃取物、蜂膠);雙胍抗菌劑(例如沙威 隆(chlorhexidine)、阿立西定(aiexidine)或奥替尼啶 (octenidine));季銨化合物(例如氯化錄蠛基σ比咬 (CPC)、氣化节烷銨、氣化十四烷基吡啶(TPC)、氣化 N-十四烷基-4-乙基吡啶(TDEPC));苯酚殺菌劑;海克 20 西定(hexetidine);奥替尼啶;血根鹼;優碘;地莫匹 醇(delmopinol) ; salifluor ;金屬離子(例如鋅鹽如捧檬 酸鋅、亞錫鹽、銅鹽、鐵鹽);血根驗(sanguinarine); 蜂膠和氧化劑(oxygenating agent)(例如過氧化氫、緩 衝過氧硼酸鈉或過氧碳酸鈉);酞酸及其鹽類;單過敢 6 201006503 酸及其鹽類和醋類;抗壞血酸硬脂酸醋;油醯基肌胺 酸’燒基硫酸鹽,二辛基硫號轴酸鹽;柳酸苯胺;漠 5 10 15 ❹ 辛派醇及其触衍生物;祕酸製船亞氯酸鹽; 以及任何上述的混合物。 1_13任何上述組成物進一步包含一美白劑。 1.14,何上述組成物進—步包含選自由過氧化物、金屬亞 f酸鹽、過職鹽、過碳酸鹽、過氧酸、次氯酸鹽及 /、、、且α所構成群組之具有美白活性的美白劑。 1.15 述組成物進—步包含過氧化氫或過氧化氫源例 化尿素或過氧化物鹽或複合物(舉例如過氧化 皿、過氧化碳酸鹽、過硼酸鹽、過氧化矽酸鹽或 過硫酸鹽;例如過氧化鱗酸每、過爛酸鈉、過氧化碳 過氧化魏姊過硫酸卸),或過氧化氫高分子 、σ物例如過氧化氫·聚乙烯°叫轴高分子複合物。 在,-具體實施例中,本發明包括組成物2G,一種包 3多支架和存在於該孔內之雖胺基酸的組成物。 本發明亦包括下列的組成物: 2.1組成物2.0其中該鹼性胺基酸係精胺酸、離胺酸、瓜 =、:胺酸、肌酸、組胺酸、二胺基丁酸、二胺基丙 & ’其鹽類及/或其組合。 2.2組j物2.〇 421其中該驗性胺基酸具有匕·構型。 2.3任組成物2.0-2.2其中該驗性胺基酸係精胺酸。 20 201006503 2.4任一組成物2 〇_2.3其中該驗性胺基酸係乙_精胺酸。 2.5任一組成物2.0_2 4包含鹽型的鹼性胺基酸。 2.6任一組成物2.0-2.5包含精胺酸磷酸鹽。 2.7任一組成物2.0-2.0包含精胺酸鹽酸鹽。 2·8任一組成物2.0-2.7包含精胺酸硫酸鹽。 2.9任一組成物2 〇_2 8包含精胺酸碳酸氫鹽。 2.10任一組成物2.0-2.9其中該鹼性胺基酸可逆地存在於該 2.11任-組成物2.〇_2.9其巾該支架係—娜其係選自聚 ,、聚曱基丙烯醆甲酯、聚胺基甲酸酯、聚乙烯對 =一甲酸醋、聚丙烯、聚苯乙烯、聚_類、生物塑 膠和生物可降解塑膠。 2.12 ^組成物2.G_2.1G其中該支㈣-生物可紐聚合 15 500/^2 ^212其中該組成物包含從約1%至約 50/°重量比的鹼性胺基酸。 2.14任一組成物! 〇_2 13 化鹽,例如選自氟化=:=== 酸納、—二 2.15 任一組成物 1〇_2.14 一 氣沙;草本萃取物和精油^含抗菌劑,其係選自三 Γ香3卒取物、瑞麵、薄荷醇、桉葉醇、香葉 酵香岸盼、檸獅'檢木醇、兒茶盼、甲基水楊酸、 20 201006503 表沒食子兒茶素沒食子酸S旨、表沒食子兒茶素、沒食 5 10 子酸、碧桃茉莉萃取物、沙棘萃取物、蜂膠);雙胍抗 菌劑(例如沙威隆、阿立西定或奥替尼啶);季銨化合物 (例如乳化綠蟻基σ比咬(CP〇、氯化节烧錄、氯化十四 燒基°比啶(TPC)、氯化Ν-十四烷基-4-乙基吡啶 (TDEPC));苯酚殺菌劑;海克西定;奥替尼啶;血根 鹼,優峨;地莫匹醇;saliflu〇r ;金屬離子(例如鋅鹽如 檸檬酸鋅、亞錫鹽、銅鹽、鐵鹽);血根鹼;蜂膠和氧 化劑(例如過氧化氫、緩衝過氧硼酸鈉或過氧碳酸鈉); 耿酸及其鹽類,單過酞酸及其齡貞和自旨類丨抗壞血酸 硬脂酸酯;油醯基肌胺酸;烷基硫酸鹽;二辛基硫琥峨鹽;_苯胺;演化杜每芬;地莫匹醇;辛派醇 及其他哌啶基衍生物;菸鹼酸製劑;亞氣酸鹽;以及 任何上述的混合物。 15 ❹ 20 2.16任何上述組成物包含一美白劑。 21H= 且成物包含選自由過氧化物、金屬亞氯酸 過爾鹽、過碳酸鹽、過氧酸、次氣酸鹽及ΐ组 口所構成群組之具有美白活性的美白劑。 /、、’ 2·18 ^何^述組成物進—步包含過氧化氫或過氧化 碟過氧化物鹽或複合物(舉例如&化 過硫酸鹽:例如過氧化 酸納、過氧化鱗酸納和過硫酸卸) 氧化叙 複合物例如過氧化氯-聚乙 9 201006503 10 15 2·19可有效應用於口腔例如利用任何裝置3 〇〜3 8之口腔 裝置的任何上龍成物,其可(i)減少或抑概牙的形 成,(1〇減J、修補或抑制早期琺瑯質病變,例如藉 :疋量光激發螢光(QLF)或電齲齒測量法(ECM)的測 定’⑽減少或抑制牙齒的去礦化及促進再礦化 減少牙齒過敏性’(v)減少或抑制齒銀炎;⑽促進口 腔内潰癌或傷口的瘡合;⑽降低產酸菌的濃度 增加精胺酸溶解菌的相對濃度;㈣抑制口腔内微生 物生物膜的形成;(X)吃糖食之後上升及/或維持牙垢 pH在至少pH 5.5的程度;(xi)減少牙垢的積聚丨㈣ 治療、緩和或減彡口腔乾燥;⑽〇清潔牙姊口腔· (xiv)減少雜:㈣奸錢自;(xvi)牙輯致鱗菌 免疫;及/或(xvii)促進包括心血管的身體健康,例如 藉由降低經由口腔組織全身性感染的可能性。 2.20 —種藉由組合說明於任何上述組成物中的成分所獲得 或得到的組成物。 Λ $ 本發明進一步提供一種裝置(裝置3.0),其係一包含 一材料的口腔器具,該第一材料係以任一組成物ι〇_【ΐ8 塗佈例如任一下列裝置: 3.1裝置3.0其中該器具係一種頭部具有附著 3.2裝置3.1其中組成物1.0-2.19中之一種舍饮' ' ° ^禋堂佈於該鬃毛。 3.3裝置3.1或3.2其中组成物1.〇_2.19中之 _ .. y. ^ T之一種塗佈於該 頭部。 20 201006503 3.4裝置3.0其中該器具係一種牙籤。 3.5裝置3.0其中該器具係一種舌苔清潔器(tongue cleaner) ° 3.6裝置3.5其中該舌苔清潔器包含清潔舌頭的表面,該表 5 面以組成物1.0-2.19中之一種塗佈。 3.7裝置3.5其中該器具係一種護口膠。 3.8裝置3.0或3.7其中該器具係一種牙齒矯正裝置例如固 ©位器。 3.9任一裝置3.0-3.7其係藉由說明於下文中的方法4或方 10 法5所製成。 本發明亦涵蓋方法4,其係一種製造用於口腔内器具的 方法包括: 1.將生物可蝕性聚合物或其單體溶解於溶劑内以形成一 溶液; 15 2.將鹼性胺基酸混合入該溶液内; © 3.從該溶液取出該器具而使該溶液塗佈於器具上;以及 4.蒸發掉該溶劑。 該器具較佳為不可溶或實質上不溶解於該溶劑。 本發明亦涵蓋方法5,其係一種製造用於口腔内器具的 20 方法包括: 1.將鹼性胺基酸與一單體掺合,該單體為可聚合以形成生 物可触性聚合物; 2.將器具浸泡入該混合物内; 11 201006503 3.從混合物内取出該器具;以及 ,可誘發單體聚合反應的條件下處理該清潔器具以形 成生物可蝕性聚合物。 本發明進一步提供一種方法(方法6),該方法包括使有 需要的人利用含有驗性胺基酸之口腔裝置例如任一裝置 3.0-3.9而可達到(i)減少或抑繼牙的形成;⑼減少、修 補或抑制早触瑯質病變,例如藉由定量光激發螢光(财) 或電㈣測的測定;⑽減少或抑制牙齒的去〇 礦化及促進再礦化;(iv)減少牙齒過敏性;(v)減少或抑制 齒齦炎’(VI)促進口腔内潰癌或傷口的療合,·⑽)降低產 酸菌的濃度;(Viii)增加精胺酸溶解菌的相對濃度:⑻抑 制口腔内微生物生物膜的形成;(χ)吃糖食之後上升及/或 維持牙垢pH在至少pH5.5的程度;⑽減少牙垢的積聚; ㈣治療、緩和或減少口腔乾燥;(xiii)清潔牙齒和口腔; (xiv)減少腐蝕;(xv)使牙齒變白;(χνί)牙齒對致齲菌免 疫,及/或(xvii)促進包括心血管的身體健康,例如藉由降❹ 低經由口腔組織全身性感染的可能性。 本發明進一步包括鹼性胺基酸於製造牙齒敦篆例如上 文中所述任一裝置3.0-3.9、例如於上文中所述製造方法例 如方法4或5,或於上文中所述方法例如方法6的用途。 本發明的其他具體實施例對於本技術領域中具有通常 知識者將是明顯的。 ' 12 201006503 【實施方式】 如此處所述,一生物可蝕性聚合物係一種藉由暴露於 口腔之後可被降解的聚合物。當該材料與口腔内的物質例 如渔液接觸時可導致降解。聚合物與口腔之_磨擦和刺 5 ❺ 10 15201006503 VI. INSTRUCTIONS: This patent application claims the benefit of U.S. Patent Application Serial No. 61/027,428, filed on Jan. TECHNICAL FIELD OF THE INVENTION The present invention provides oral devices comprising a basic amino acid and compositions for making such devices, and methods of making and using such devices. [Prior Art] The use of arginine and other basic amino acids in oral care has been suggested and is believed to have significant benefits in combating scaly tooth formation and tooth sensitivity. Oral basic amino acids have been thought to be metabolized by certain non-carious bacteria, such as S. sanguis, which will compete with the dental caries of the oral cavity, such as S. mutans. effect. The arginine-dissolving bacteria can use ammonia to produce ammonia by using arginine and other basic amino acids, while the caries bacteria metabolize sugar to lactic acid to lower the plaque pH and demineralize the teeth, resulting in 20 fines. Amino acid treatment of the oral cavity is currently done with dentifrice grades such as DenClude®. It is also recommended to formulate food and beverage products with arginine. Although the beneficial effects of arginine may be sustained in the oral cavity for several hours after treatment, such as brushing, chewing gum, or eating an acid-rich food, it is preferred to develop a composition that delivers arginine to the oral cavity. And devices, such as synergistic compositions containing arginine, or alone. Appliances for use in the oral cavity are well known in the art and include, for example, teeth 3 201006503 brushing to tongue floss, toothpicks, mouth guards, and dental braces such as braces and retainers. Such an instrument, although treatable by an experimental amino acid, may leak or invade the surface of the device and require time-consuming repetitive processing and is extremely inconvenient to the user. The handling of such appliances can also be extremely complex, and incomplete or incorrect handling of the silo b results in too little or too much of the test amino acid being incorporated into the surface of the appliance. There is therefore a need to create compositions, devices and methods that overcome these difficulties. SUMMARY OF THE INVENTION The present invention relates to a composition and device capable of delivering a basic amino acid such as arginine to the oral cavity for use in, for example, (1) reducing or inhibiting the formation of dental caries; ((1) reducing, repairing or inhibiting early enamel lesions , for example, by quantitative photoexcited fluorescence (QLF) or electrocautery measurement (ECM); (iii) reducing or inhibiting demineralization of teeth and promoting remineralization; (iv) reducing tooth hypersensitivity; Reduce or reduce gingivitis; 〇i) promote the healing of oral ulcers or wounds; (νϋ) reduce the concentration of acid-producing bacteria; (viii) increase the relative concentration of arginine-dissolving bacteria; (ix) inhibit oral cavity Formation of microbial biofilm; raising or decreasing tartar pH to at least pH 5.5; (xi) reducing tartar accumulation; (xii) cleaning teeth and mouth; (xiii) treating dry mouth; (xiv) improving body health 20 Kang; and / or (xv) whitening teeth. Such compositions and devices may be used alone or in combination with other compositions comprising an amino acid, such as a dentifrice composition, to deliver an amino acid to the oral cavity. The invention thus comprises a composition comprising composition 1.0 comprising a basic amino acid which is incorporated into a bioerodable polymer. 201006503 The present invention also includes the following compositions: 1.1 Composition 1.0 wherein the basic amino acid is arginine, lysine, citrulline, ornithine, creatine, histidine, diamine butyric acid , diaminopropionic acid, salts thereof and/or combinations thereof. 5 m 10 15 _ 20 1·2 Composition 1·0 or u wherein the basic amino acid has an L-configuration. 1.3 Any of the above compositions wherein the basic amino acid is arginine. 1.4 Any of the above compositions wherein the basic amino acid is L-arginine. 1.5 Any of the above compositions comprises a basic amino acid of a salt type. 1.6 Any of the above compositions comprises arginine phosphate. 1.7 Any of the above compositions comprises a arginine hydrochloride. 1.8 Any of the above compositions comprises arginine sulfate. 1.9 Any of the above compositions comprises arginine hydrogencarbonate. 1.10 Any of the above compositions wherein the bioerodible polymer is selected from the group consisting of poly(lactic acid), poly(glycolic acid) and copolymers; polydioxanone, poly(glutamic acid ethyl vinegar), poly(hydroxybutyrate) ), poly(hydroxyvalerate) and copolymer; polycaprolactone, polyanhydride, poly(orthoester), poly(iminocarbonate), polyester decylamine, polyesteramine, polycyanide Acrylates, polyphosphazenes, copolymers and other aliphatic polyesters, or suitable copolymers thereof, include copolymers of poly-L-lactic acid and poly-ε-caprolactone, fibrin (fibrin) ), collagen, glycosaminoglycan, oligosaccharides, polysaccharides, chondroitin, chitosan, alginate, fibring, fibrinogen, cellulose, starch, glucose Sugar, dextrin, hyaluronic acid, heparin, elastin; multi-block copolymers, for example, constructed from glycolide, 5 201006503, C parent-fed _ _ internal brewing base unit; and polyethylene glycol and poly(ester, amine) The polymer or analogue 'based on leucine, albinoic acid and/or arginine' Having one or more diols and one or more dicarboxylic Acid. 2 hereinafter, the composition further comprises a fluorinated orphan present in the pores, for example, selected from the group consisting of stannous fluoride, sodium fluoride, potassium fluoride, sodium fluorocarbonate monofluorophosphate, ammonium fluorite, Amine oxides, fluorinated, and combinations thereof. 〇丨 任 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 12 , eucalyptus yeast, geraniol, carvacrol, citric acid, eucalyptus, catechol, sulfhydryl salicylic acid, epigallocatechin gallate, epidicoletic Subcatechin, gallic acid, jasmine extract, seabuckthorn extract, propolis; bismuth antibacterial agent (eg chlorhexidine, aiexidine or oloti) Octonidine; quaternary ammonium compounds (eg, chlorinated ruthenium sigma ratio (CPC), vaporized naphthenic ammonium, gasified tetradecylpyridine (TPC), gasified N-tetradecyl- 4-ethylpyridine (TDEPC)); phenol bactericide; hexetidine; octenidine; erythromycin; iodine; delmopinol; salifluor; metal ions (such as zinc Salt such as zinc citrate, stannous salt, copper salt, iron salt); blood test (sanguinarine); propolis and oxidant (oxygenating agent) (for example Hydrogen, buffered sodium peroxodisodium or sodium percarbonate); citric acid and its salts; single over 6 201006503 acid and its salts and vinegar; ascorbic acid stearic acid vinegar; Sulfate, dioctylsulfonate; aniline sulphate; desert 5 10 15 辛 octyl alcohol and its tactile derivatives; secret acid boat chlorite; and any of the above mixtures. 1_13 Any of the above compositions further comprises a whitening agent. 1.14, wherein the composition further comprises a group selected from the group consisting of a peroxide, a metal pentoxide, a salt, a percarbonate, a peroxyacid, a hypochlorite, and/or A whitening agent with whitening activity. 1.15 The composition further comprises hydrogen peroxide or a source of hydrogen peroxide to exemplify a urea or a peroxide salt or a complex (for example, a peroxidation vessel, a peroxycarbonate, a perborate, a peroxyformate or a Sulfate; for example, peroxidic squaric acid per sodium, sodium sulphate, carbon monoxide, persulfate, persulfate, or hydrogen peroxide polymer, σ, such as hydrogen peroxide, polyethylene, called a shaft polymer compound . In a particular embodiment, the invention includes a composition 2G, a package comprising 3 scaffolds and a composition of the amino acid present in the pores. The present invention also includes the following compositions: 2.1 Composition 2.0 wherein the basic amino acid is arginine, lysine, melon =, amine acid, creatine, histidine, diamine butyric acid, Aminopropyl & 'its salts and/or combinations thereof. 2.2 group j substance 2. 〇 421 wherein the test amino acid has a 匕 configuration. 2.3 Any composition 2.0-2.2 wherein the in situ amino acid is arginine. 20 201006503 2.4 Any composition 2 〇 _2.3 wherein the test amine acid is B-arginine. 2.5 Any of the compositions 2.0_2 4 contains a basic amino acid of a salt type. 2.6 Any of the compositions 2.0-2.5 contains arginine phosphate. 2.7 Any of the compositions 2.0-2.0 comprises arginine hydrochloride. Any composition 2.0 to 2.7 containing arginine sulfate. 2.9 Any of the compositions 2 〇_2 8 contains arginine hydrogencarbonate. 2.10 Any of the compositions 2.0-2.9 wherein the basic amino acid is reversibly present in the 2.11-component-2. 〇 2.9, the towel of the stent is selected from the group consisting of poly, polydecyl propylene armor Ester, polyurethane, polyethylene pair = monocarboxylic acid vinegar, polypropylene, polystyrene, poly-type, bio-plastic and biodegradable plastic. 2.12^Composition 2. G_2.1G wherein the branch (iv)-biocopolymer 15 500/^2 ^ 212 wherein the composition comprises from about 1% to about 50/° by weight of a basic amino acid. 2.14 any composition! 〇_2 13 salt, for example selected from the group consisting of fluorinated =:=== acid sodium, -2. 2.15, any composition 1〇_2.14 a gas sand; herbal extracts and essential oils ^ containing an antibacterial agent, which is selected from the group of three Xiang 3 Stroke, Reed, menthol, eucalyptol, fragrant leaves, fragrant vines, lemon lion 'check lignin, catechu, methyl salicylic acid, 20 201006503 table catechins Acidic acid S, epigallocatechin, no acid 5 10 acid, jasmine extract, seabuckthorn extract, propolis); biguanide antibacterial agent (such as saviron, alistidine or octopini) Acridine); quaternary ammonium compounds (eg, emulsified green ant base σ ratio bite (CP〇, chlorination burn, chlorinated tetradecylpyridinium (TPC), cesium chloride-tetradecyl-4-B Pyridine bactericide (TDEPC)); phenol bactericide; hexocildine; octenidine; radixine, sorghum; delmopinol; saliflu〇r; metal ions (such as zinc salts such as zinc citrate, stannous Salt, copper salt, iron salt); blood base; propolis and oxidant (such as hydrogen peroxide, buffered sodium peroxyborate or sodium percarbonate); citric acid and its salts, monoperic acid and its age and self Anti-small blood Acid stearate; oleic acid creatinine; alkyl sulphate; dioctyl sulphate; aniline; evolution dubufen; delmopinol; octyl alcohol and other piperidinyl derivatives; A nicotinic acid preparation; a sulfite; and a mixture of any of the above. 15 ❹ 20 2.16 Any of the above compositions comprises a whitening agent. 21H = and the composition comprises a salt selected from the group consisting of peroxides, metal chlorite, and a whitening active whitening agent composed of a carbonate, a peroxyacid, a hypoxanthate, and a sputum group. /,, ' 2·18 ^What is the composition of the step comprising hydrogen peroxide or peroxidation a dish of a peroxide salt or a complex (for example, & persulfate: for example, sodium peroxide, sodium perchlorate and persulfate). Oxidized complexes such as chlorine peroxide - polyethyl 9 201006503 10 15 2 19 can be effectively applied to the oral cavity, for example, any upper body of any oral device using any device, which can (i) reduce or inhibit the formation of teeth, (1) reduce J, repair or inhibit early enamel Lesions, for example, by the measurement of photoluminescence (QLF) or electrocautery measurement (ECM) Reduce or inhibit demineralization of teeth and promote remineralization to reduce tooth hypersensitivity' (v) reduce or inhibit dental gingivitis; (10) promote oral ulceration or wound sore; (10) reduce the concentration of acidogenic bacteria to increase spermine The relative concentration of acid-dissolving bacteria; (4) inhibiting the formation of microbial biofilm in the oral cavity; (X) increasing the pH of the tartar after eating confectionery and/or maintaining the pH of the tartar at least pH 5.5; (xi) reducing the accumulation of tartar (4) treatment, mitigation Or reduce dryness of the mouth; (10) 〇 clean the gums of the mouth · (xiv) reduce miscellaneous: (4) money from the (4) dental plaque immunization; and / or (xvii) promote cardiovascular health, such as By reducing the likelihood of systemic infection through the oral tissue. 2.20 - A composition obtained or obtained by combining the components described in any of the above compositions.本 $ The present invention further provides a device (apparatus 3.0) which is an oral device comprising a material which is coated with any of the following materials 〇 ΐ 8 such as any of the following devices: 3.1 device 3.0 The device is a type of head having an attached 3.2 device 3.1 wherein one of the compositions 1.0-2.19 is served on the 'bristle'. 3.3 Apparatus 3.1 or 3.2 wherein one of the components 1.. _. ^ T of the composition 1. 〇 2.. 19 is applied to the head. 20 201006503 3.4 Device 3.0 wherein the device is a toothpick. 3.5 Apparatus 3.0 wherein the apparatus is a tongue cleaner ° 3.6 apparatus 3.5 wherein the tongue cleaner comprises a surface for cleaning the tongue, the surface of which is coated with one of the compositions 1.0-2.19. 3.7 Device 3.5 wherein the device is a mouthguard. 3.8 Apparatus 3.0 or 3.7 wherein the apparatus is an orthodontic device such as a keeper. 3.9 Any of the devices 3.0-3.7 is made by the method 4 or the method 10 described below. The invention also encompasses method 4, which is a method of making an oral device comprising: 1. dissolving a bioerodible polymer or a monomer thereof in a solvent to form a solution; The acid is mixed into the solution; © 3. The device is removed from the solution to apply the solution to the device; and 4. The solvent is evaporated. The device is preferably insoluble or substantially insoluble in the solvent. The invention also encompasses method 5, which is a method of making an oral device 20 comprising: 1. blending a basic amino acid with a monomer that is polymerizable to form a biotactable polymer 2. Soaking the device into the mixture; 11 201006503 3. Removing the device from the mixture; and treating the cleaning device under conditions that induce polymerization of the monomer to form a bioerodible polymer. The present invention further provides a method (Method 6) which comprises (i) reducing or inhibiting the formation of teeth by a person in need thereof using an oral device containing an amidine-based acid, such as any device 3.0-3.9; (9) reducing, repairing or inhibiting early contact with enamel lesions, such as by quantitative light-exciting fluorescence (Finance) or electricity (4) measurements; (10) reducing or inhibiting demineralization of teeth and promoting remineralization; (iv) reduction Tooth allergic; (v) reduce or inhibit gingivitis' (VI) to promote oral cancer or wound healing, (10)) reduce the concentration of acid-producing bacteria; (Viii) increase the relative concentration of arginine-dissolving bacteria: (8) inhibiting the formation of microbial biofilm in the oral cavity; (χ) increasing and/or maintaining the pH of the tartar at a pH of at least 5.5 after eating the confection; (10) reducing the accumulation of tartar; (4) treating, alleviating or reducing the dryness of the mouth; (xiii) Clean teeth and mouth; (xiv) reduce corrosion; (xv) whiten teeth; (χνί) teeth are immune to cariogenic bacteria, and/or (xvii) promote cardiovascular health including, for example, by lowering The possibility of systemic infection of the oral tissue. The invention further comprises a basic amino acid for the manufacture of a tooth such as any of the devices 3.0-3.9 described above, such as the method of manufacture described above, such as method 4 or 5, or the method described above, such as method 6 the use of. Other embodiments of the invention will be apparent to those of ordinary skill in the art. [12 201006503 [Embodiment] As described herein, a bioerodible polymer is a polymer which can be degraded by exposure to the oral cavity. Degradation can occur when the material comes into contact with substances in the mouth, such as fish fluids. Polymer and oral _ friction and thorn 5 ❺ 10 15

20 激亦可導致降解。視聚合物的厚度,僅與σ腔接觸的聚合 物表面被降解。 、有效量”係足以在口腔内產生所欲治療或預防效應 而不造成例如刺激或過敏反應之不良副作用的數量。 除非另有明示,否則此處所述鹼性胺基酸包括作為游 離鹼或鹽類之鹼性胺基酸。 用於口腔的器具已為本技術領域中所習知,以及包括 牙刷、刮舌器、牙線、牙籤、護口膠,以及牙齒矯正 二,如牙套和固位器。用於口腔内的器具並不僅偈限於 月/絮和牙_正裝置。其他ϋ具包括可仙於卩腔内之設 鳩安慰器峨器),以及幼兒和 咬牙環。其他11具包括非設計用於口 腔仁人類可能將該物件含於口中的物件,例如筆和錯筆。 具軸可驗性胺基酸處理例如表面塗佈^ 理。ίΐΐΓ性胺基酸併人該器具㈣避免需重複地處 該器具含驗性胺基酸的生物可餘性聚合物塗佈 表面係Si 同方法製造該器具°由於聚合物的 釋放:=τ,因此可將聚合物表面的驗性胺基酸 被腐餘,因物表面在例Γ常用於口腔内時 而供應釋入口腔内的額外驗性胺基酸。 13 201006503 亦可使用多孔材料而直接將鹼性胺基酸併入該器具 内。該器具可自多孔材料製造,或可被其塗佈。通常,該 材料含存在驗性胺基酸於其中的孔隙。胺基酸可在使用該 器具例如置於口腔内時被釋出。若孔隙釋出其所含之胺基 5 酸’則該多孔材料可藉由暴露該鹼性胺基酸來處理以再充 填該孔隙。因此’該鹼性胺基酸可從該孔隙被釋出或駐留 其内。 用於製造使用於口腔内之器具的方法以及製造其之組 成物亦為本技術領域中所熟知的。本發明亦預期以包含生 10 物可钱性聚合物及鹼性胺基酸的組成物製造此類器具,或 具有驗性胺基酸的多孔支架。 生物可蝕性聚合物已為本技術領域中具有通常知識者 所熟知,以及包括聚(乳酸)、聚(乙醇酸)和共聚物;聚二吟 酮、聚(麩胺酸乙酯)、聚(羥基丁酸酯)、聚(羥基戊酸酯)和 15 共聚物;聚己内酯、聚酸酐、聚(原酸酯)、聚(亞胺基碳酸 酯)、聚酯醯胺類、聚酯胺類、聚氰丙烯酸酯類、聚磷腈類, 共聚物及其他脂族聚酯,或其適當共聚物包括聚-L-乳酸和 聚e -己内酯的共聚物;混合物、共聚物,及其組合。其他 有用聚合物亦包括聚丙烯酸酯類、聚丙烯酸甲酯類、聚胺 2〇 基曱酸酯類、聚烯烴類、聚鹵化乙烯類、聚鹵化亞乙烯類、 聚乙烯醚類、芳香聚乙烯類、聚丙烯腈類、樹脂、聚矽氧 烷類、環氧樹脂和聚四氟乙烯。其他有用聚合物包括或基 於血纖維蛋白、膠原蛋白、葡萄胺聚醣 (glycosoaminoglycan)、寡醣和多聽、軟骨素、麟S旨質、構 201006503 聚葡萄胺糖、褐藻酸略、纖維蛋白(fi =、纖維素、澱粉、葡聚糠、糊精、玻尿酸、肝:: t蛋白I該聚合物亦可為1錄共聚物例如建構自乙 ΐ二丙父醋、卜己内0旨和聚乙二醇的基礎單位。有用的 t物亦包括聚(醋·醢胺)聚合物或類似物,其以白胺酸、 類和一或多種二甲酸I 選擇地具有—或多種二元醇 1020 can also cause degradation. Depending on the thickness of the polymer, only the surface of the polymer that is in contact with the σ cavity is degraded. An effective amount" is an amount sufficient to produce a desired therapeutic or prophylactic effect in the oral cavity without causing adverse side effects such as irritation or an allergic reaction. Unless otherwise indicated, the basic amino acid described herein includes as a free base or Alkaline amino acids for salts. Apparatus for oral use is well known in the art and includes toothbrushes, tongue scrapers, dental floss, toothpicks, mouthguards, and orthodontics, such as braces and solids. The device used in the oral cavity is not limited to the month/float and the tooth_positive device. Other cookware includes a set of comforter devices that can be placed in the cavity, as well as the infant and the teething ring. The other 11 Includes articles that are not designed for oral humans, such as pens and erroneous pens, which may be included in the mouth. Axial-acceptable amino acid treatments such as surface coatings. ΐΐΓ ΐΐΓ amino acid and the device (4) Avoid the need to repeatedly place the biodegradable polymer containing the test amine acid on the surface of the device. The same method is used to manufacture the device. Due to the release of the polymer: =τ, the surface amine of the polymer can be used. Base acid is rotted The surface is supplied with an additional test amine in the mouth of the mouth when it is often used in the oral cavity. 13 201006503 It is also possible to use a porous material to directly incorporate a basic amino acid into the device. The device can be self-porous. Manufactured, or coated with it. Typically, the material contains pores in which an amino acid is present. The amino acid can be released when the device is placed, for example, in the oral cavity. The amine 5 acid' can be treated by exposing the basic amino acid to refill the pores. Thus the basic amino acid can be released or retained from the pore. Methods of making an appliance for use in the oral cavity and compositions for making same are also well known in the art. The present invention also contemplates the manufacture of a composition comprising a bioavailable polymer and a basic amino acid. Classes, or porous scaffolds having an amidine-based acid. Bioerodible polymers are well known to those of ordinary skill in the art, and include poly(lactic acid), poly(glycolic acid) and copolymers; Diterpene ketone, poly(glutamic acid ), poly(hydroxybutyrate), poly(hydroxyvalerate) and 15 copolymer; polycaprolactone, polyanhydride, poly(orthoester), poly(iminocarbonate), polyester decylamine Classes, polyesteramines, polycyanoacrylates, polyphosphazenes, copolymers and other aliphatic polyesters, or suitable copolymers thereof, include copolymers of poly-L-lactic acid and poly-caprolactone; , copolymers, and combinations thereof. Other useful polymers also include polyacrylates, polymethyl acrylates, polyamines, phthalic acid esters, polyolefins, polyhalogenated vinyls, polyhalogenated vinylenes, Polyvinyl ethers, aromatic polyethylenes, polyacrylonitriles, resins, polyoxyalkylenes, epoxy resins and polytetrafluoroethylene. Other useful polymers include or based on fibrin, collagen, and glycosaminoglycans. (glycosoaminoglycan), oligosaccharide and polysynthesis, chondroitin, lin S, quality 201006503 polyglucosamine, alginate, fibrin (fi =, cellulose, starch, glucosinolate, dextrin, hyaluronic acid, liver :: t protein I The polymer may also be a recorded copolymer, for example, constructed from acetamidine Propan parent vinegar, Bu 0 caprolactone and polyethylene glycol purpose base units. Useful t materials also include poly(vinegar decylamine) polymers or the like which optionally have - or a plurality of diols with leucine, a class and one or more dicarboxylic acids I.

is Q 20 所ιΓ如從單體形纽崎合物的方法已為本技術領域中 °誘發聚合的方法已為本技術領域中所習知,例I 溶劑内、暴露於包括可見和UV輻射之輕射,以及 空」孔支料本技觸域巾所胃知,錢包㈣膠、陶 =其他材料。歸及其形成為本技術領域中所熟知以 ^聚乙缚、聚甲基丙烯酸甲醋、聚胺基甲酸賴 矛H一甲酸醋、聚丙稀、聚笨乙稀、聚醯胺、生物塑职 2物可降解歸。孔_大小極為重要其原因為小⑽ ^無法吸收和釋㈣驗性胺基酸,以及大⑽將需持續的 ^載。在本發明的—個具體實施例中,該孔_直徑平均 為從約10微米至約5〇〇微米例如約1〇微米、2〇微米、3: 微米、4G微米、5G微米、6〇微米、7G微米、8G微米、 微米、1GG微米、2GG微米、微米或微米直捏。 可被用於本發明組成物内的鹼性胺基酸不僅包括天秋 驗|生胺基酸例如精胺酸、離胺酸和組胺酸亦包括分子内具 有祕和絲的任何錄絲酸。目此,雜胺基酸包括 201006503 但不侷限於精胺酸、離胺酸、瓜胺酸、鳥胺酸、肌酸、組 胺酸、二胺基丁酸、二胺基丙酸,其鹽類或其組合。在一 特定具體實施例中,該鹼性胺基酸係選自精胺酸、瓜胺酸 和鳥胺酸’較佳為精胺酸例如L-精胺酸。 鹼性胺基酸在其游離驗或鹽型聚合之前或期間可被加 入該生物可蚀性聚合物。如此處所述,提及一鹼性胺基酸 時亦包括其鹽類。由於本發明的組成物和裝置擬被用^口 腔内,因此用於本發明之鹽類在提供的數量和濃度之下'、 需對於該用途為安全。適當鹽類包括在提供的數量和遭^ 之下通常被視為生理上可接受之醫藥上可接受鹽的技= 習知鹽類。生理上可接受鹽包括衍自醫藥上可接受無 有機酸類或驗類者,例如可形成生理上可接受 3 的酸加成鹽類例如鹽酸鹽或演化鹽,以及可形。生理_ 15 子之鹼的鹼加成鹽,例如衍自鹼金屬 : 驗土金屬如鈣和痒者。可妥丨丨# am 1丄 辦或 序辦得㈣彻本技㈣域中已知的標準 士發明組成物包含—有效量的驗性胺基酸。因此, ,、且成物可包含從約1%至約50%重量比 約卜2、3、4、 U/。重罝比的驗性胺基酸,例, 10、15、20、25、30、35、40 或 4气0/ 個具體實施例中,該鹼性胺基酸可溶解。 内。在一較佳具體實施例中, =白』 的粒度而使其用該胺基酸較佳為具有足‘ ;腔内時不造成口腔的刺激。該胺我· 20 201006503 較佳為均勻分佈於該聚合物内。 在一個具體實施例中該聚合物係一陰離子聚合物 如聚紐鹽聚合物如丙稀酸鹽聚合物或共聚物,其中該驗 性胺基酸與聚合物内的叛酸基團形成鹽。 5 纟本發明的—個具體實施例中,該生物可錄聚人物 或多孔支架選擇性地包含-有效量的亂化物或氣離子^。 f組成物内可使用廣泛不同的氟離子產生材料作為可溶性 ❹ 氟化物源。適當氟離子產生材料的實例請參考授予Briner 等人的美國專利案號3,535,42丨;授予Parran,Jr等人的美國 1〇 專利案號4,885,155以及授予Widder等人的美國專利案號 3’678’154,藉由引述將其併入於此。代表性氟離子源包括 但不侷限於氟化亞錫、敗化納、氟化鉀、單氣鱗酸納、氣 矽酸鈉、氟矽酸銨、氟化胺、氟化銨,及其組合。在某此 具體實例中,該氟離子源包括氟化亞錫、氟化鈉、惫ς 15 及其混合物。 參 在本發明的另一具體實施例中,該生物可蝕性聚合物 或多孔支架可選擇性地包含一防腐劑或抗微生物劑以進一 步增強鹼性胺基酸的有益效應,該防腐劑或抗微生物係選 自二氯沙;草本萃取物和精油(例如迷迭香萃取物、瑞香酚、 20 薄荷醇、桉葉醇、曱基水揚酸);雙胍抗菌劑(例如沙咸隆、 阿立西疋(alexidine)或奥替尼咬(〇ctenidine));季錢化合物 (例如氯化鯨蠟基η比啶);苯酚殺菌劑;海克西定 (hexetidine);優碘;地莫匹醇(delm〇pin〇1) ;salifluor ;金屬 離子(例如鋅鹽如彳宁檬酸鋅);血根驗(sangUinarine);蜂膠; 17 201006503 及其組合。 當塗佈於一器具上時,該生物聚合物或多孔支架較佳 為具有不妨礙該器具使用的足夠薄度,但具有使其後正常 使用之器具上例如使用3、4、5、10、15、20、25、30、60 5 或90次之後保留足夠量聚合物的厚度。該器具的正常使用 將視特定器具而定。該生物聚合物的厚度可從約〇 1微米至 約3000微米,約1微米、5微米、1〇微米、25微米、50 微米、100微米、250微米、500微米、1〇〇〇微米、2〇〇〇微 米或約3000微米的厚度。塗佈層的厚度將視特定器具而定。© 10 本發明組成物亦可含有香料。可被用於本發明實務的 調味劑包括,但不侷限於精油和各種的調味醛類、酯類、 醇類,以及類似材料。精油的實例包括留蘭香油、薄荷油、 冬清油、黃樟油、丁香油、鼠尾草油、桉葉油、馬鬱蘭油、 肉桂油、檸檬油、萊姆精油、葡萄柚油和橙油。此類化學 15 物質亦可使用曱醇、香芹_ (carvone)和大茴香腦 (anethole)。本發明組成物亦含有著色劑。香料和著色劑的 用途為幫助測定該支架是否含該胺基酸,或生物可姓 ❹ 合物的被降解程度。 Λ 本發明組成物亦可被用作為口腔内的黏著劑,例如與 料矯正牙套使狀牙套雜著劑。本發明域物亦可用 作為製造器具的黏著劑’例如點著牙刷頭至其刷柄。本發 明亦可被用作為牙科用密封劑,例如保護塗料。 實例1 以包含40%重量比L-精胺酸和香料如薄荷的生物可蝕 201006503 性聚合物塗佈適用於接觸性運動 面在使賴職降解㈣口膠。聚合物表 抑餘牙的形成;減少、修補以減少或 少或抑制牙齒的去礦化及促進再礦化,^_變’減 炎;降低產_的纽;增加精 、或抑制齒齦Is Q 20 ι Γ 从 的 的 的 的 的 的 的 单体 的 的 单体 的 的 的 的 的 的 的 的 单体 单体 单体 单体 单体 单体 单体 单体 单体 诱发 单体 单体 单体 单体 单体 单体 单体 单体 单体 单体 单体 单体 is 单体Light shot, and empty "holes", this technology touches the area of the stomach, wallet (four) glue, pottery = other materials. And its formation is well known in the art as polyetherbinder, polymethyl methacrylate, polyurethane ruthenium H-formic acid vinegar, polypropylene, polystyrene, polyamine, bioplastics 2 substances can be degraded. The pore size is extremely important because of the small (10) ^ inability to absorb and release (iv) the amino acid, and the large (10) will continue to be loaded. In a particular embodiment of the invention, the pores have an average diameter of from about 10 microns to about 5 microns, such as about 1 inch, 2 microns, 3: microns, 4G microns, 5G microns, 6 microns. , 7G micron, 8G micron, micron, 1GG micron, 2GG micron, micron or micron straight pinch. The basic amino acid which can be used in the composition of the present invention includes not only the sky test, but also the amino acid such as arginine, lysine and histidine, and any silk-loading acid having a secret filament in the molecule. . Thus, the heteroamino acid includes 201006503 but is not limited to arginine, lysine, citrulline, ornithine, creatine, histidine, diaminobutyric acid, diaminopropionic acid, and salts thereof. Class or a combination thereof. In a particular embodiment, the basic amino acid is selected from the group consisting of arginine, citrulline and ornithine' preferably arginine such as L-arginine. The basic amino acid can be added to the bioerodible polymer before or during its free or salt type polymerization. As mentioned herein, reference to a basic amino acid also includes salts thereof. Since the compositions and devices of the present invention are intended to be used in the mouth cavity, the salts used in the present invention are below the quantity and concentration provided, and are required to be safe for this use. Suitable salts include those which are generally considered to be physiologically acceptable pharmaceutically acceptable salts in the amounts provided and which are conventionally known. Physiologically acceptable salts include those derived from pharmaceutically acceptable organic acids or testers, for example, acid addition salts such as hydrochlorides or evolution salts which form physiologically acceptable 3, and which are morphological. Physiological _ base addition salts of 15 bases, such as derived from alkali metals: soil test metals such as calcium and itching. It can be done by the # am 1丄 or the pre-programmed (4). The standard invention composition contained in the technical (4) domain contains an effective amount of the test amine acid. Thus, the composition may comprise from about 1% to about 50% by weight, about 2, 3, 4, U/. The analog amino acid of the heavy enthalpy ratio, for example, 10, 15, 20, 25, 30, 35, 40 or 4 gas / in a specific embodiment, the basic amino acid is soluble. Inside. In a preferred embodiment, the particle size of = white is such that the amino acid preferably has a foot'; the cavity does not cause irritation to the mouth. The amine I 20 201006503 is preferably uniformly distributed within the polymer. In a particular embodiment, the polymer is an anionic polymer such as a polynuclear salt polymer such as an acrylate polymer or copolymer wherein the test amine acid forms a salt with a tickic acid group within the polymer. In a particular embodiment of the invention, the biocollectable person or porous scaffold selectively comprises an effective amount of chaotic or gas ions. A wide variety of fluoride ion generating materials can be used in the f composition as a source of soluble cerium fluoride. For an example of a suitable fluoride ion-generating material, reference is made to U.S. Patent No. 3,535,42, issued to the entire entire entire entire entire entire entire entire entire entire entire content '678' 154, which is incorporated herein by reference. Representative fluoride ion sources include, but are not limited to, stannous fluoride, sodium hydride, potassium fluoride, sodium monosulfate, sodium citrate, ammonium fluoroantimonate, amine fluoride, ammonium fluoride, and combinations thereof. . In some embodiments, the fluoride ion source comprises stannous fluoride, sodium fluoride, cesium 15 and mixtures thereof. In another embodiment of the invention, the bioerodible polymer or porous scaffold may optionally comprise a preservative or antimicrobial agent to further enhance the beneficial effects of the basic amino acid, the preservative or The antimicrobial system is selected from the group consisting of diclosan; herbal extracts and essential oils (such as rosemary extract, eugenol, 20 menthol, eucalyptol, decyl salicylic acid); biguanide antibacterial agents (such as Sha Xianlong, A Alexidine or tenctenidine; quaternary compound (eg, cetyl cyanopyrene); phenol bactericide; hexetidine; iodine; Alcohol (delm〇pin〇1); salifluor; metal ion (such as zinc salt such as zinc citrate); blood root test (sangUinarine); propolis; 17 201006503 and combinations thereof. When applied to an implement, the biopolymer or porous scaffold preferably has a sufficient thickness that does not interfere with the use of the device, but has an apparatus for normal use thereafter, for example, 3, 4, 5, 10, A sufficient amount of polymer is retained after 15, 20, 25, 30, 60 5 or 90 times. The normal use of the appliance will depend on the particular appliance. The biopolymer may have a thickness of from about 1 micron to about 3000 microns, about 1 micron, 5 micron, 1 micron, 25 micron, 50 micron, 100 micron, 250 micron, 500 micron, 1 micron, 2 〇〇〇 microns or a thickness of about 3000 microns. The thickness of the coating layer will depend on the particular appliance. © 10 The composition of the present invention may also contain a fragrance. Flavoring agents that can be used in the practice of the present invention include, but are not limited to, essential oils and various flavoring aldehydes, esters, alcohols, and the like. Examples of essential oils include spearmint oil, peppermint oil, winter oil, sassafras oil, clove oil, sage oil, eucalyptus oil, marjoram oil, cinnamon oil, lemon oil, lime oil, grapefruit oil and orange oil. These chemistry 15 substances can also use sterols, carvone and anethole. The compositions of the present invention also contain a colorant. The use of perfumes and colorants is to aid in determining whether the scaffold contains the amino acid, or the degree to which the bio-complex is degraded. Λ The composition of the present invention can also be used as an adhesive in the oral cavity, for example, a corrective braces to make a braces. The field of the invention may also be used as an adhesive for the manufacture of the appliance', e.g., with the brush head attached to its handle. The invention can also be used as a dental sealant, such as a protective coating. Example 1 Bioerodible coating containing 40% by weight of L-arginine and a perfume such as peppermint 201006503 The polymer coating is suitable for the contact movement of the surface to degrade the (4) gum. The polymer forms the formation of the residual teeth; reduces, repairs to reduce or inhibit the demineralization of the teeth and promotes remineralization, reduces the inflammation; reduces the production of the ton; increases the precision, or inhibits the gums.

1010

^該護Π膠可進-步降解該聚合物,當護口^再具有 薄何味道時·者可確《合物6被私轉。,、 實例2 w二具ί 5G微米平均孔_多孔塑膠支架製造奶嘴。將 該奶嘴浸潰於包含精胺酸碳酸氫⑽清潔溶液内並且該 精胺酸碳酸氫鹽被吸收入孔内。 實例3 將實例2的奶嘴給予嬰兒正常使用,即吸和吹。當嬰 兒吸和吮該奶嘴時,精胺酸碳酸氫鹽被釋入口腔内而抑制 口腔内微生物生物膜的形成。 實例4 將實例3的經使用奶嘴浸潰入包含精胺酸碳酸氫鹽的 清潔溶液内。 實例5 以包含精胺酸及顏色如紅色的生物可餘性聚合物塗佈 透明牙刷頭。將鬃毛貼附至頭部,及使該頭部連接—^ The viscous gel can further degrade the polymer, and when the mouthpiece has a thin taste, it can be confirmed that the compound 6 is eclipsed. , Example 2 w two ί 5G micron average hole _ porous plastic bracket manufacturing pacifier. The teat is immersed in a cleaning solution containing arginine hydrogencarbonate (10) and the arginine hydrogencarbonate is absorbed into the pores. Example 3 The nipple of Example 2 was given to the baby for normal use, i.e., suction and blowing. When the baby sucks and licks the nipple, arginine bicarbonate is released into the cavity to inhibit the formation of microbial biofilm in the oral cavity. Example 4 The used nipple of Example 3 was dipped into a cleaning solution containing arginine hydrogencarbonate. Example 5 A transparent toothbrush head was coated with a biorenewable polymer comprising arginine and a color such as red. Attach the bristles to the head and connect the head —

一把柄D 20 201006503 口腔内使用該牙刷時該聚合物可被降解而釋出精胺酸。當 該頭部不再呈紅色時使用者則得知需更換該頭部或牙刷。 【圖式簡單說明】 5 無 【主要元件符號說明】 無A handle D 20 201006503 When the toothbrush is used in the oral cavity, the polymer can be degraded to release arginine. When the head is no longer red, the user knows that the head or toothbrush needs to be replaced. [Simple description of the diagram] 5 None [Key component symbol description] None

2020

Claims (1)

201006503 七、申請專利範圍: 1. 一種含有游離或鹽型鹼性胺基酸之組成物,該驗性胺 基酸係被嵌入生物可钱性聚合物。 2. 如申請專利範圍第1項之組成物,其中該生物可敍性 聚合物係選自聚(乳酸)、聚(乙醇酸)和共聚物;聚二噚 酮、聚(麩胺酸乙酯)、聚(羥基丁酸酯)、聚(羥基戊酸醋) 和共聚物;聚己内酯、聚酸酐、聚(原酸酯)、聚(亞胺基 碳酸酯)、聚酯醢胺類、聚酯胺類、聚氰丙烯酸醋類、 聚磷腈類’共聚物及其他脂族聚酯,或其適當共聚物包 括聚-L-乳酸和聚ε -己内酯的共聚物、血纖維蛋白、膠 原蛋白、葡萄胺聚醣(glyCOS〇amin〇glyCan)、募醣、多 膽、軟骨素、聚葡萄胺糖(chit〇san)、褐藻酸酯、纖維 蛋白(fibring)、纖維蛋白原、纖維素、澱粉、葡聚糖、 糊精、破尿酸、肝素、彈性蛋白;多嵌段共聚物例如建 構自乙交酯、丙交酯、己内酯的基礎單位;以及聚 乙—醇和聚(酯-醯胺)聚合物或類似物,其以白胺酸、苯 丙胺酸及/或精胺酸為基礎,選擇地具有一或多種二元醇 類和—或多種二甲酸類。 3· 一種組成物’其包括具有孔隙之支架及存在該孔隙間 之鹼性胺基酸。 4. 如申清專利範圍第3項之組成物,其中該支架係塑膠。 5. 如申清專利範圍第3或4項之組成物,其中該支架係 選自聚乙締、聚甲基丙烯酸曱酯、聚胺基曱酸酯、聚乙 21 201006503 烯對苯二曱酸酯、聚丙烯、聚苯乙烯、聚醯胺類、生物 塑膠、生物可降解塑膠,及其組合。 6. 如申請專利範圍第3〜5項中任一項之組成物,其中該 鹼性胺基酸可逆地存在於該孔隙間。 5 7. 如上述申請專利範圍中任一項之組成物,其中該鹼性 胺基酸係精胺酸、離胺酸、瓜胺酸、鳥胺酸、肌酸、 組胺酸、二胺基丁酸、二胺基丙酸,其鹽及/或其組 合。 8. 如上述申請專利範圍中任一項之組成物,其中該鹼性 ίο 胺基酸具有L-構型。 9. 如上述申請專利範圍中任一項之組成物,其中該鹼性 胺基酸係精胺酸。 10. 如上述申請專利範圍中任一項之組成物,其中該驗性 胺基酸係L-精胺酸。 15 11.如上述申請專利範圍中任一項之組成物,其包含鹽型 的驗性胺基酸。 12. 如上述申請專利範圍中任一項之組成物,其包含精胺 酸磷酸鹽。 13. 如上述申請專利範圍中任一項之組成物,其包含精胺 20 酸鹽酸鹽。 14. 如上述申請專利範圍中任一項之組成物,其包含一精 22 ❹ 10 參 15 201006503 胺酸鹽及一陰離子聚合物。 15.如上述申請專利範圍中任一項之組成物,其包含 酸碳酸氫鹽。 16· -種裝置’其包括使用如中請專利範圍第卜15項中 任一項之組成物塗佈之器具。 17. :::專利範圍第16項之裝置,其中該器具係包括 18. 第17項之裝置,其中該鬃毛被如申 π專利範圍第卜15項中任一項之組成物塗佈。 19. 利範圍第17或18項之裝置,其中該頭部被 申❺專利範圍第1〜15項中任—項之組成物塗佈。 Γ如申請專利範圍第16項之裝置,其中該器具係牙藏。 利範圍第16項之裝置,其中該器具係舌答 22. :=:圍表=裝置,其中該舌答清潔器包 項細如巾請專利範圍第 上5項中任一項之組成物塗佈。 币 23. 如申請專利範圍第16項之裝置 膠。 ,、T通器具係護口 4.如申請專利範圍第16項之裝 矯正裝置。 Μ其中該益具係牙齒 23 20 201006503201006503 VII. Scope of Application: 1. A composition containing a free or salt-type basic amino acid embedded in a bio-nicifiable polymer. 2. The composition of claim 1, wherein the biorepresentable polymer is selected from the group consisting of poly(lactic acid), poly(glycolic acid) and copolymer; polydioxanone, poly(ethyl glutamate) ), poly(hydroxybutyrate), poly(hydroxyvalerate) and copolymer; polycaprolactone, polyanhydride, poly(orthoester), poly(iminocarbonate), polyester decylamine , polyesteramines, polycyanoacrylates, polyphosphazenes' copolymers and other aliphatic polyesters, or suitable copolymers thereof, including copolymers of poly-L-lactic acid and poly-ε-caprolactone, blood fibers Protein, collagen, glycosaminoglycan (glycos〇amin〇glyCan), sugar-raising, polybiliary, chondroitin, chit〇san, alginate, fibring, fibrinogen, Cellulose, starch, dextran, dextrin, uric acid, heparin, elastin; multi-block copolymers such as base units constructed from glycolide, lactide, caprolactone; and polyethyl alcohol and poly( An ester-guanamine polymer or analog, optionally based on leucine, phenylalanine and/or arginine Or more diols and class - or more dicarboxylic Acid. 3. A composition comprising a scaffold having pores and a basic amino acid present between the pores. 4. If the composition of the third paragraph of the patent scope is claimed, the bracket is plastic. 5. The composition of claim 3 or 4, wherein the stent is selected from the group consisting of polyethyl amide, polymethyl methacrylate, polyamino phthalate, polyethyl 21 201006503 olefin terephthalic acid Ester, polypropylene, polystyrene, polyamines, bioplastics, biodegradable plastics, and combinations thereof. 6. The composition of any one of claims 3 to 5, wherein the basic amino acid is reversibly present between the pores. The composition according to any one of the preceding claims, wherein the basic amino acid is arginine, lysine, citrulline, ornithine, creatine, histidine, diamine Butyric acid, diaminopropionic acid, salts thereof and/or combinations thereof. 8. The composition of any of the preceding claims, wherein the basic ίο amino acid has an L-configuration. A composition according to any one of the preceding claims, wherein the basic amino acid is arginine. A composition according to any one of the preceding claims, wherein the testable amino acid is L-arginine. A composition according to any one of the preceding claims, which comprises a salt-type test amine acid. A composition according to any one of the preceding claims, which comprises arginine phosphate. A composition according to any one of the preceding claims, which comprises a spermine 20 acid salt. 14. The composition of any of the preceding claims, comprising a fine 22 ❹ 10 gin 15 201006503 aminate and an anionic polymer. A composition according to any one of the preceding claims, which comprises an acid hydrogencarbonate. A device comprising a device coated with a composition according to any one of the above-mentioned patents. 17. The device of claim 16, wherein the device comprises the device of item 17, wherein the bristles are coated with a composition according to any one of the claims of claim 516. 19. The device of item 17 or 18, wherein the head is coated with a composition of any one of items 1 to 15 of the patent application. For example, the device of claim 16 of the patent application, wherein the device is a dental device. The device of claim 16, wherein the device is a tongue and a tongue. 22. :=: a wall-mounted device, wherein the tongue-and-stick cleaner item is as thin as a towel, and the composition of any one of the fifth items of the patent scope is coated. cloth. Coin 23. For example, apply for the device glue in item 16 of the patent scope. , T Tong appliance system protection mouth 4. If the application of the scope of the scope of the article 16 correction device. ΜThe benefit of the teeth is 23 20 201006503 25. 5 10 一種方法,复·^ 橡姑+ ,丹了(1)減少或抑制蛀牙的形成;(ii)減少、 P制早期琺螂質病變,例如藉由定量光激發螢光 =)或電鶴齒測量法(ECM)的測定;⑽減少或抑制 的去礦化及促進再礦化;(iv)減少牙齒過敏性 K或抑制齒酿炎;(vi)促進口腔内潰瘍或傷口的癒 ~ ( ii)降低產酸菌的濃度·,(viii)增加精胺酸溶解菌 的相對濃度·’(IX)抑制口腔内微生物生物顏形成;⑻ 甜食之後上升及/或維持牙垢pH在至少5 5的程 度,。(XI)減少牙垢的積聚;(xii)治療、緩和或減少口腔 乾燥;(X111)清潔牙齒和口腔;(xiv)減少腐姓;㈣使 牙齒變白;(XVI)使牙齒對致齲菌免疫;及/或(xvii)促進 包括心血官的身體健康’例如藉由降低經由口腔組織全25. 5 10 A method, complex ^ ^ aunt +, Dan (1) reduce or inhibit the formation of caries; (ii) reduce, P system early enamel lesions, such as by quantitative light to stimulate fluorescence =) or Determination of electric crane measurement (ECM); (10) reduction or inhibition of demineralization and promotion of remineralization; (iv) reduction of tooth hypersensitivity K or inhibition of tooth brewing; (vi) promotion of oral ulcers or wound healing ~ ( ii) reduce the concentration of acid-producing bacteria ·, (viii) increase the relative concentration of arginine-dissolving bacteria · '(IX) inhibit the formation of microbial bio-forms in the mouth; (8) rise after the sweets and / or maintain the pH of the tartar at least 5 The extent of 5,. (XI) reduce the accumulation of tartar; (xii) treat, alleviate or reduce dry mouth; (X111) clean teeth and mouth; (xiv) reduce rot; (4) whiten teeth; (XVI) make teeth immune to sputum And/or (xvii) promote the physical health of the heart, including by reducing the entire organization through the mouth 身性感染的可能性’其包含使用__口腔裝置,該裝置包 含驗性胺基酸,其係板據個人的需要。 15 26. 27. 28. 如申請專利範圍第25項之方法,其帽裝置係一種 如申請專利範圍弟16〜24項中任一項之裝置。 —種鹼性胺基酸於製造牙齒裝置之用途。 如申請專利範圍第27項之用途,其中該裝置係一種 如申請專利範圍第16〜24項中任一項之裝置。 24 201006503 四、指定代表圖: (一) 本案指定代表圖為:第(無)圖。 (二) 本代表圖之元件符號簡單說明: 無 五、本案若有化學式時,請揭示最能顯示發明特徵的化學式: 無 201006503 發明糞利說明書 98J9The possibility of a body infection' which involves the use of a __oral device containing an indicating amino acid, which is tied to the individual's needs. 15 26. 27. 28. The method of claim 25, wherein the cap device is a device as claimed in any one of claims 16 to 24. - The use of a basic amino acid for the manufacture of dental devices. The apparatus of claim 27, wherein the apparatus is a device as claimed in any one of claims 16 to 24. 24 201006503 IV. Designation of representative drawings: (1) The representative representative of the case is: (No). (2) A brief description of the symbol of the representative figure: None 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: None 201006503 Inventive manure instruction 98J9 (本說明書格式、順序,請勿任意更動,※記號部分請勿填寫) ※申請案號: ※申請曰: 分類: 、發明名矛冉.(中文/英文) 組成物及裝置(二) COMPOSITIONS AND DEVICES 二、中文發明摘要: 本發明提供包含鹼性胺基酸的口腔器具及製造此類11 具的組成物,以及製造和使用此類器具的方法。 ©三、英文發明摘要: The present invention provides oral instruments comprising a basic amino acid, to compositions for making such instruments, and to methods of making and using such instruments. 1 201006503 六、發明說明: 此專利申請案主張擁有2008年2月8曰提出之美國專 利申請案序號61/027,428的權利,藉由引述將其内容併入 於此。 八 【發明所屬之技術領域】 本發明提供包含鹼性胺基酸的口腔器具及製造此類器 具的組成物,以及製造和使用此類器具的方法。 ° 【先前技術】 已建議使用精胺酸和其他鹼性胺基酸於口腔保健以及 涊為其在對抗齲齒形成和牙齒敏感具有顯著效益。已認為 口腔内鹼性胺基酸被某些非生齲齒類型細菌例如血鏈球菌 (S· sanguis)所代謝,其將與口腔内牙齒的生齲齒菌例如變異 鏈球菌(S. mutans)產生競爭作用❶精胺酸溶解菌能利用精胺 酸和其他鹼性胺基酸產生氨而提高環境pH,同時齲齒菌則 將糖代謝成乳酸而降低牙斑pH和使牙齒去礦化,最後造成 ^^齒。 使用精胺酸處理口腔’目前係以牙粉(dentifrice )組 成物例如DenClude®來完成。亦建議以精胺酸配製成食物和 飲料產品。雖然經處理例如刷牙、P且嚼口香糖或吃富含精 胺酸食物之後精胺酸的有益效應可在口腔内持續數分鐘或 數小時之久’但是較佳為發展可傳遞精胺酸至口腔的其他 組成物和裝置,例如協同含精胺酸的組成物,或單獨。 用於口腔的器具已為技術領域中所熟知及包括例如牙 3 201006503 刷、刮舌器、牙線、牙籤、護口膠(mouth guard ),以及牙 齒矯正裝置例如牙套和固位器。此類器具雖然可被鹼性胺〆 基酸所處理,但是該鹼性胺基酸可能產生滲漏或侵蝕該器 ’ 具表面而需要費時地重複處理並且對使用者而言極不方 便。此類器具的處理亦可能極為複雜,並且不完全或不正 確的處理可能導致過少或過多的鹼性胺基酸被併入該器具 的表面。因此亟需創造可克服這些困難的組成物、裝置和 方法。 ❹ 【發明内容】 本發明係關於能將鹼性胺基酸如精胺酸傳遞至口腔的 組成物及裝置其用於例如⑴減少或抑制姓牙的形成;(^) 減少、修補或抑制早期琺瑯質病變,例如藉由定量光激發 螢光(QLF)或電齲齒測量法(ECM)的測定;(iii)減少或抑制 牙齒的去礦化及促進再礦化;(iv)減少牙齒過敏性;(v)減 少或抑制齒齦炎;(vi)促進口腔内潰瘍或傷口的癒合;(vii) 降低產酸菌的濃度;(viii)增加精胺酸溶解菌的相對濃度;❹ (ix)抑制口腔内微生物生物膜的形成;(x)使牙垢pH上升 及/或維持在至少pH 5.5的程度;(xi)減少牙垢的積聚;(xii) 清潔牙齒和口腔;(xiii)治療口腔乾燥;(xiv)改善身體健 康;及/或(xv)使牙齒變白。可單獨使用此類的組成物和裝 置或協同3其他驗性胺基酸的組成物如牙粉組成物以傳遞 驗性胺基酸至口腔。 本發明因此包含組成物1.0的一種包括嵌入生物可蝕 性(bioerodable)聚合物内之鹼性胺基酸的組成物。 201006503 本發明亦包括下列的組成物: 1.1組成物1.0其中該鹼性胺基酸係精胺酸、離胺酸、瓜胺 酸、鳥胺酸、肌酸、組胺酸、二胺基丁酸、二胺基丙 酸,其鹽及/或其組合。 1,2組成物I·0或U其中該鹼性胺基酸具有L-構型。 1.3任何上述組成物其中該鹼性胺基酸係精胺酸。 1.4任何上述組成物其中該鹼性胺基酸係^精胺酸。 m(Please do not change the format and order of this manual, please do not fill in the ※ part) ※Application number: ※Application曰: Classification: Invented name spear. (Chinese/English) Composition and device (2) COMPOSITIONS AND DEVICES II. Abstract of the Invention: The present invention provides an oral appliance comprising a basic amino acid and a composition for the manufacture of such an article, and a method of making and using such an appliance. ©3, English Abstract: The present invention provides oral instruments comprising a basic amino acid, to compositions for making such instruments, and to methods of making and using such instruments. 1 201006503 VI. Description of the invention: This patent application claims to have 2008 The rights of U.S. Patent Application Serial No. 61/027,428, filed on Jan. VIII Technical Field to Which the Invention The present invention provides an oral appliance comprising a basic amino acid and a composition for manufacturing the same, and a method of manufacturing and using the same. ° [Prior Art] It has been suggested that arginine and other basic amino acids are used in oral care and that sputum has significant benefits in combating caries formation and tooth sensitivity. Oral basic amino acids have been thought to be metabolized by certain non-carious bacteria, such as S. sanguis, which will compete with the dental caries of the oral cavity, such as S. mutans. The action of arginine-dissolving bacteria can increase the environmental pH by using arginine and other basic amino acids to produce ammonia, while the caries bacteria metabolize the sugar to lactic acid to lower the plaque pH and demineralize the teeth, resulting in ^ ^ teeth. Treatment of the oral cavity with arginine is currently done with a dentifrice composition such as DenClude®. It is also recommended to formulate food and beverage products with arginine. Although the beneficial effects of arginine after treatment such as brushing, P and chewing gum or eating a diet rich in arginine may last for a few minutes or hours in the mouth 'but better development can deliver arginine to the oral cavity Other compositions and devices, such as synergistic compositions containing arginine, or alone. Appliances for the oral cavity are well known in the art and include, for example, teeth 3 201006503 brushes, tongue scrapers, dental floss, toothpicks, mouth guards, and dental correction devices such as braces and retainers. While such an appliance can be treated with a basic amine hydrazinoic acid, the basic amino acid may leak or erode the surface of the apparatus requiring time consuming repetitive treatment and is extremely inconvenient for the user. The handling of such devices can also be extremely complex, and incomplete or improper handling can result in too little or too much alkaline amino acid being incorporated into the surface of the device. There is therefore a need to create compositions, devices and methods that overcome these difficulties. SUMMARY OF THE INVENTION The present invention relates to a composition and apparatus capable of delivering a basic amino acid such as arginine to the oral cavity for use in, for example, (1) reducing or inhibiting the formation of a tooth; (^) reducing, repairing or inhibiting early珐琅 lesions, such as by quantitative photo-excited fluorescence (QLF) or electro-tooth measurement (ECM); (iii) reducing or inhibiting demineralization of teeth and promoting remineralization; (iv) reducing tooth hypersensitivity; (v) reduce or inhibit gingivitis; (vi) promote oral ulcer or wound healing; (vii) reduce the concentration of acidogenic bacteria; (viii) increase the relative concentration of arginine-dissolving bacteria; ❹ (ix) inhibit oral cavity (x) increasing the pH of the plaque and/or maintaining it to at least pH 5.5; (xi) reducing the accumulation of tartar; (xii) cleaning the teeth and mouth; (xiii) treating the dry mouth; (xiv Improve your health; and/or (xv) whiten your teeth. Such compositions and devices may be used alone or in combination with other compositions of a testeric acid such as a dentifrice composition to deliver an amino acid to the oral cavity. The invention thus comprises a composition of composition 1.0 comprising a basic amino acid embedded in a bioerodable polymer. 201006503 The present invention also includes the following compositions: 1.1 Composition 1.0 wherein the basic amino acid is arginine, lysine, citrulline, ornithine, creatine, histidine, diamine butyric acid , diaminopropionic acid, salts thereof and/or combinations thereof. 1, 2 Composition I·0 or U wherein the basic amino acid has an L-configuration. 1.3 Any of the above compositions wherein the basic amino acid is arginine. 1.4 Any of the above compositions wherein the basic amino acid is arginine. m 1.5任何上述組成物包含鹽型的鹼性胺基酸。 1.6任何上述組成物包含精胺酸磷酸鹽。 1.7任何上述組成物包含精胺酸鹽酸鹽。 1.8任何上述組成物包含精胺酸硫酸鹽。 1.9任何上述組成物包含精胺酸碳酸氫鹽。 1.10任何上述組成物其中該生物可蝕性聚合物係選自聚 (乳酸)、聚(乙醇酸)和共聚物;聚二畤酮、聚(麵胺酸乙 酯)、聚(羥基丁酸酯)、聚(羥基戊酸酯)和共聚物;聚己 内酯、聚酸酐、聚(原酸酯)、聚(亞胺基碳酸酯)、聚酯 醯胺類、聚酯胺類、聚氰丙烯酸酯類、聚磷腈類,共 聚物及其他脂族聚酯,或其適當共聚物包括聚-L-乳酸 和聚ε-己内醋(e-caprolactone)的共聚物、血纖維蛋 白(fibrin )、膠原蛋白、葡萄胺聚醣 (glycosoaminoglycan )、募醣、多醣、軟骨素、聚葡 萄胺糖(chitosan)、褐藻酸酯、纖維蛋白(faring)、纖 維蛋白原、纖維素、澱粉、葡聚糖、糊精、玻尿酸、 肝素、彈性蛋白;多嵌段共聚物例如建構自乙交酯、 5 201006503 丙交S曰、ε _己内酯的基礎單位;以及聚乙二醇和聚(酯 或類似物’以白胺酸、苯丙胺酸及/或精 月女酸為基礎’選擇地具有—或多種二元醇類和一或多 種二甲酸類。 1’11任何下文中組成物進—步包含存在於孔隙内的的氣化 孤例如選自氟化亞錫、氟化納、氟化卸、單氟磷酸 納敗石夕酸納、氟梦酸銨、氟化胺、氟化錢,及其組 合。 1.12任=下文中組成物進一步包含抗菌劑選自三氣沙;草 本萃取物和精油(例如迷迭香萃取物、茶樹萃取物、木 蘭萃取物、瑞香酚、薄荷醇、桉葉醇、香葉醇、香芹 酚、檸檬醛、檜木醇、兒茶酚、甲基水揚酸、表沒食 子兒茶素沒食子酸酯(epigall〇catechin gaiiate)、表沒 食子兒茶素、沒食子酸、碧桃茉莉萃取物、沙棘 (sea-buckthorn)萃取物、蜂膠);雙胍抗菌劑(例如沙威 隆(chlorhexidine)、阿立西定(alexidine)或奥替尼啶 (octenidine));季銨化合物(例如氣化錄躐基吡咬 (CPC)、氯化苄烧敍、氯化十四烧基吡咬(TpC)、氣化 N-十四烷基-4-乙基吡。定(TDEPC));苯酚殺菌劑;海克 西定(hexetidine);奥替尼咬;血根驗;優蛾;地莫匹 醇(delmopinol) ; salifluor ;金屬離子(例如鋅鹽如擰樣 酸鋅、亞錫鹽、銅鹽、鐵鹽);血根鹼(sanguinarine); 蜂膠和氧化劑(oxygenating agent)(例如過氧化氫、、緩 衝過氧硼酸鈉或過氧碳酸鈉);酞酸及其鹽類;單過駄 201006503 =及其_和_ ;抗壞錢硬崎自旨;祕基肌胺 酸,烷基硫酸鹽;二辛基硫琥珀酸二 才=(domiphen b腿ide);地莫匹醇(仏_〇1); 辛底醇及其他㈣基触物; 以及任何上述的齡物。 ㈣I, 1.13任何上述組成物進一步包含一美白劑。1.5 Any of the above compositions comprises a basic amino acid of a salt type. 1.6 Any of the above compositions comprises arginine phosphate. 1.7 Any of the above compositions comprises a arginine hydrochloride. 1.8 Any of the above compositions comprises arginine sulfate. 1.9 Any of the above compositions comprises arginine hydrogencarbonate. 1.10 Any of the above compositions wherein the bioerodible polymer is selected from the group consisting of poly(lactic acid), poly(glycolic acid) and copolymers; polydioxanone, poly(ethyl oleate), poly(hydroxybutyrate) ), poly(hydroxyvalerate) and copolymer; polycaprolactone, polyanhydride, poly(orthoester), poly(iminocarbonate), polyester decylamine, polyesteramine, polycyanide Acrylates, polyphosphazenes, copolymers and other aliphatic polyesters, or suitable copolymers thereof, include copolymers of poly-L-lactic acid and poly-ε-caprolactone, fibrin (fibrin) ), collagen, glycosaminoglycan, sugar, polysaccharide, chondroitin, chitosan, alginate, faring, fibrinogen, cellulose, starch, glucoside Sugar, dextrin, hyaluronic acid, heparin, elastin; multi-block copolymers such as basal units constructed from glycolide, 5 201006503, S, ε-caprolactone; and polyethylene glycol and poly(ester or similar) ''based on leucine, phenylalanine and/or quercetin' - or a plurality of diols and one or more dicarboxylic acids. 1 '11 Any of the following compositions further comprising a gasification orphan present in the pores, for example selected from the group consisting of stannous fluoride, sodium fluoride, fluorination Unloading, sodium sulphate monosodium sulphate, ammonium fluoromonate, fluorinated amine, fluorinated money, and combinations thereof. 1.12 任 = hereinafter, the composition further comprises an antibacterial agent selected from the group consisting of trigassal; herbal extracts and Essential oils (eg rosemary extract, tea tree extract, magnolia extract, eugenol, menthol, eucalyptol, geraniol, carvacrol, citral, camphorol, catechol, methyl salicylic acid Epigall〇catechin gaiiate, epigallocatechin, gallic acid, jasmine extract, sea-buckthorn extract, propolis; A bismuth antibacterial agent (such as chlorhexidine, alexidine or octenidine); a quaternary ammonium compound (such as gasification, thiopurine (CPC), benzyl chloride , tetradecyl pyridyl chloride (TpC), gasified N-tetradecyl-4-ethylpyridine (TDEPC)); phenol Bacterial agent; hexetidine; otetidine bite; blood root test; excellent moth; delmopinol; salifluor; metal ions (such as zinc salts such as zinc sulphate, stannous salt, copper Salt, iron salt); sanguinarine; propolis and oxidizing agent (such as hydrogen peroxide, buffered sodium peroxyborate or sodium percarbonate); tannic acid and its salts; single pass 201006503 = and its _ and _; anti-bad money hard Qi Zizhi; secret base sarcosine, alkyl sulfate; dioctyl succinic acid two only = (domiphen b leg ide); delmopinol (仏 _ 〇 1); octyl alcohol and other (four) based contacts; and any of the above-mentioned ages. (d) I, 1.13 Any of the above compositions further comprises a whitening agent. U4任何上述組成物進一步包含選自由過氧化物、金屬亞 氯酸鹽、過硼酸鹽、過碳酸鹽、過氧酸、次氣酸鹽及 其組合所構成群組之具有美白活性的美白劑。| .15任何上述組成物進一步包含過氧化氫或過氧化氣源例 如過氧化尿素或過氧化物鹽或複合物(舉例如過氧化 磷酸鹽、過氧化碳酸鹽、過硼酸鹽、過氧化矽酸醆戈 過硫酸鹽;例如過氧化填酸約、過硼酸納、過氧化妒 酸鈉、過氧化磷酸鈉和過硫酸鉀),或過氧化氫高分子 複合物例如過氧化氫_聚乙烯*7比洛咬_高分子複合物U4 Any of the above compositions further comprises a whitening active whitening agent selected from the group consisting of peroxides, metal chlorites, perborates, percarbonates, peroxyacids, hypoxides, and combinations thereof. Any of the above compositions further comprises hydrogen peroxide or a source of peroxygen gas such as urea peroxide or a peroxide salt or a complex (for example, peroxyphosphate, peroxycarbonate, perborate, peroxydecanoic acid)醆 过 persulfate; for example, peroxyacid acid, sodium perborate, sodium perrhenate, sodium persulfate and potassium persulfate), or hydrogen peroxide polymer complex such as hydrogen peroxide _ polyethylene * 7 Bilo bite_polymer complex 在另一具體實施例中’本發明包括組成物2.0,一種包 含多孔支架和存在於該孔内之鹼性胺基酸的組成物。 本發明亦包括下列的組成物: 2.1組成物2.0其中該鹼性胺基酸係精胺酸、離胺酸、瓜胺 酸、鳥胺酸、肌酸、組胺酸、二胺基丁酸、二胺基内 酸,其鹽類及/或其組合。 2.2組成物2.0或2.1其中該鹼性胺基酸具有L-構型。 2.3任一組成物2.0-2.2其中該鹼性胺基酸係精胺酸。 7 201006503 2.4任一組成物2.3 2.5任一組成物2.〇< 4 2.6任一組成物2.〇、2$ 2.7任一組成物2.〇、2 6 2.8任一組成物2.^ 2.9任一組成物2.8 2.10任一組成物2.〇、2 & 孔内。 其中該驗性胺基酸係L-精胺酸。 包含鹽型的鹼性胺基酸。 包含精胺酸磷酸鹽。 包含精胺酸鹽酸鹽。 包含精胺酸硫酸鹽。 包含精胺酸碳酸氫鹽。 其中該鹼性胺基酸可逆地存在於該 組成物2.〇、^9 乙烯、聚甲基中該支架係一塑膠’其係選自聚 酸醋、聚丙、广甲赌、聚胺基曱酸醋、聚乙稀對 Θ 2.11 任 苯二甲酸酯 膠和生物可降解塑髁、聚苯乙烯、聚醯胺類、生物塑 2.12任一組成物2.μ 物。 其中該支架係一生物可蝕性聚合 2.13任一組成物2.〇、2^ 50%重量比的峰性 其中该組成物包含從約1%至約 2.14任-組成物1.〇、2 =酸。 化鹽,例如選自氣化進一步包含存在於孔隙内的的氟 酸鈉、氟矽酸鈉、&亞錫、氟化鈉、氟化鉀、單氟磷 組合。 ^夕酸錢、氣化胺、氟化敍,及其 2.15任一組成物l.〇、2 W 氣沙;草本萃取物和步包含抗菌劑,其係選自三 取物、木蘭萃取物、瑞如香萃取物、茶樹萃 醇、香芹酚、檸檬醛、檜未醇^ ^膏案 知、兒茶酚、甲基水楊酸、 201006503 表沒食子兒茶素沒食子酸酯、表沒食子兒茶素、沒食 子酸、碧桃茉莉萃取物、沙棘萃取物、蜂膠);雙脈抗 菌劑(例如沙威隆、阿立西定或奥替尼啶);季錢化合物 (例如氯化鯨蠟基吡啶(CPC)、氯化苄烷銨、氯化十四 烷基吡啶(TPC)、氯化N-十四烷基-4-乙基吼咬 (TDEPC));苯酚殺菌劑;海克西定;奥替尼咬;血根 鹼;優碘;地莫匹醇;salifluor;金屬離子(例如鋅鹽如 〇 檸檬酸鋅、亞錫鹽、銅鹽、鐵鹽);血根鹼;蜂膠和氧 化劑(例如過氧化氫、緩衝過氧硼酸鈉或過氧碳酸鈉); 駄酸及其鹽類;單過酞酸及其鹽類和酯類;抗壞血酸 硬脂酸酯;油醯基肌胺酸;烷基硫酸鹽;二辛基硫破 ί白酸鹽;柳酸苯胺;漠化杜每芬;地莫匹醇;‘:醇° 及其他哌啶基衍生物;菸鹼酸製劑;亞氣酸鹽;以及 任何上述的混合物。 2.16任何上述組成物包含一美白劑。 ❹ 2.17任何上述組成物包含選自由過氧化物、金屬亞氯酸 鹽、過硼酸鹽、過碳酸鹽、過氧酸、次氣酸鹽及其組 合所構成群組之具有美白活性的美白劑。 ' 2.18任何上述組成物進一步包含過氧化氫或過氧化氫源例 如過氧化尿素或過氧化物鹽或複合物(舉例如過氧化 磷酸鹽、過氧化碳酸鹽、過硼酸鹽、過氧化矽酸鹽或 過硫酸鹽;例如過氧化磷酸鈣、過硼酸鈉、過氧化碳 酸鈉、過氧化磷酸鈉和過硫酸鉀),或過氧化氫高分子 複合物例如過氧化氫_聚乙烯σ比咯啶酮高分子複合物。 9 201006503 2.19可有效應用於口腔例如利用任何裝置3騎8之口腔 裝置的任何上述組成物,其可(i)減少❹卩舳牙的形 成;⑼減少、修補或抑制早期琺瑯質病變,例 由定量光激發螢光(QLF)或電齲齒測量法(ecm)的測 定,(111)減少或抑制牙齒的去礦化及促進再礦化 減少牙齒過敏性;(V)減少或抑制齒齦炎;(vi)促進L 腔内潰癌或傷口騎合;(vii)降低產_的濃 增加精胺酸溶解菌的相對濃度;⑽抑制口腔又’, 物生物膜的形成;(X)吃糖食之後上升及/ ΡΗ在至少ρΗ5.5的程度:⑽減少牙垢的積聚 治療、緩和或減少口腔乾燥;_)清潔牙齒和口腔. ㈣減少腐使牙齒變白;㈣牙齒對致鶴菌 免疫;及/或(xvii)促進包括心血管的身_康,例如 藉由降低經由口腔組織全身性感染的可能性。 2.2〇 -種藉她合說日胳任何上敝成物巾的成 或得到的組成物。 又传 本發明進-步提供-難置(裝置3 Q),其係 -材料的口腔器具’該第-材料係以任_組成物弟 塗佈例如任一下列裝置: · δ 3.1裝置3.G其中該器具係-種頭部具有附著 3.2裝置3Λ其中組成物叫.19中之一種塗佈於 3.3裝置U或3.2其中紙成物aw中之一種^=該 頭部。 Λ 201006503 3.4裝置3.0其中該器具係一種牙籤。 3.5裝置3.0其中該器具係一種舌苔清潔器(tongue cleaner) ° 3.6裝置3.5其中該舌苔清潔器包含清潔舌頭的表面,該表 面以組成物1.0-2.19中之一種塗佈。 3.7裝置3.5其中該器具係一種護口膠。 3.8裝置3·0或3.7其中該器具係一種牙齒矯正裝置例如固 ❹ 位器。 3.9任一裝置3.0-3.7其係藉由說明於下文中的方法4或方 法5所製成。 本發明亦涵蓋方法4,其係一種製造用於口腔内器具的 方法包括: 1. 將生物可#性聚合物或其單體溶解於溶劑内以形成一 溶液; 2. 將鹼性胺基酸混合入該溶液内; ❿ 3.從該溶液取出該器具而使該溶液塗佈於器具上;以及 4.蒸發掉該溶劑。 該器具較佳為不可溶或實質上不溶解於該溶劑。 本發明亦涵蓋方法5,其係一種製造用於口腔内器具的 方法包括: 1. 將鹼性胺基酸與一單體掺合,該單體為可聚合以形成生 物可姓性聚合物; 2. 將器具浸泡入該混合物内; 201006503 3. 從混合物内取出該器具;以及 4. 在可誘發單體聚合反應的條件下處理該清潔器具以形 成生物可蝕性聚合物。 本發明進一步提供一種方法(方法6),該方法包括使有 需要的人湘含有㈣胺基酸之口腔裝❹】如任一裝置 3.0-3.9而可達到(i)減少或抑制姓牙的形成;⑼減少、修 補或抑制早期_質病變,例如藉由定量光激發螢光(QLF) 或電麵齒測量法(ECM)的測定;⑽減少或抑制牙齒的去❹ 礦化及促進再礦化;(iv)減少牙齒過敏性;(v)減少或抑制 齒齦炎;(vi)促進口腔内潰瘍或傷口的癒合;(vU)降低產 酸菌的濃度;(Viii)增加精胺酸溶解菌的相對濃度;⑽抑 制口腔内微生物生物膜的形成:⑻吃糖食之後上升及/或 維持牙垢pH在至少pH 5.5的程度;⑽減少牙垢的積聚; (xii)治療、緩和或減少口腔乾燥;(xm)清潔牙齒和口腔; (xiv)減少腐蝕;(xv)使牙齒變白;(xvi)牙齒對致齲菌免 疫;及/或(xvii)促進包括心血管的身體健康,例如藉由降❹ 低經由口腔組織全身性感染的可能性。 本發明進一步包括鹼性胺基酸於製造牙齒裝置例如上 文中所述任一裝置3.0-3.9、例如於上文中所述製造方法例 如方法4或5 ’或於上文中所述方法例如方法6的用途。 本發明的其他具體實施例對於本技術領域中具有通常 知識者將是明顯的。 12 201006503 【實施方式】 如此處所述 一生物可蝕性聚合物係一種藉由暴 口腔之後可被降解的聚合物。當該材料與口腔内的= 如淫液接觸時可導致降解。聚合物與σ腔之間的磨 激亦可導致降解。視聚合物的厚度,僅與口腔 物表面被降解。 J取口In another embodiment, the invention comprises a composition 2.0, a composition comprising a porous scaffold and a basic amino acid present in the pore. The present invention also includes the following compositions: 2.1 Composition 2.0 wherein the basic amino acid is arginine, lysine, citrulline, ornithine, creatine, histidine, diaminobutyric acid, Diaminolacetic acid, salts thereof and/or combinations thereof. 2.2 Composition 2.0 or 2.1 wherein the basic amino acid has the L-configuration. 2.3 Any of the compositions 2.0-2.2 wherein the basic amino acid is arginine. 7 201006503 2.4 Any composition 2.3 2.5 Any composition 2. 〇 < 4 2.6 Any composition 2. 〇, 2$ 2.7 Any composition 2. 〇, 2 6 2.8 Any composition 2. 2.9 Any composition 2.8 2.10 any composition 2. 〇, 2 & Wherein the test amine acid is L-arginine. A basic amino acid containing a salt form. Contains arginine phosphate. Contains arginine hydrochloride. Contains arginine sulfate. Contains arginine bicarbonate. Wherein the basic amino acid is reversibly present in the composition 2. 〇, ^9 ethylene, polymethyl, the scaffold is a plastic selected from the group consisting of polyacid vinegar, polypropylene, gambling, polyamine hydrazine Sour vinegar, polyethylene bismuth 2.11 phthalate gel and biodegradable plastic enamel, polystyrene, polyamide, bioplastic 2.12 any composition 2.μ. Wherein the scaffold is a bioerodible polymerization 2.13 of any composition 2. 〇, 2 ^ 50% by weight of the peak property wherein the composition comprises from about 1% to about 2.14 of any composition 1. 〇, 2 = acid. The salt, for example selected from the group consisting of sodium fluorofluoride, sodium fluorophthalate, & stannous, sodium fluoride, potassium fluoride, monofluorophosphate, is present in the pores.夕酸钱, aerochemical amine, fluorinated, and any composition of 2.15, 〇, 2 W air sand; herbal extracts and steps comprising an antibacterial agent selected from the group consisting of three extracts, magnolia extract, Rui Ruxiang extract, tea tree extract alcohol, carvacrol, citral, decyl alcohol ^ ^ paste case, catechol, methyl salicylic acid, 201006503 epigallocatechin gallate, Epigallocatechin, gallic acid, jasmine extract, sea buckthorn extract, propolis); double-pulse antibacterial agents (eg, saviron, alistidine or octenidine); For example, cetylpyridinium chloride (CPC), benzalkonium chloride, tetradecylpyridinium chloride (TPC), N-tetradecyl-4-ethylphthalate (TDEPC), phenol sterilization Agent; hexetidine; otinib bite; blood base; iodine; delmopinol; salifluor; metal ions (such as zinc salts such as zinc citrate, stannous, copper, iron); Root base; propolis and oxidant (such as hydrogen peroxide, buffered sodium peroxyborate or sodium percarbonate); citric acid and its salts; monoperic acid and its salts and esters; ascorbic acid Acid ester; oil sulfhydryl creatinine; alkyl sulphate; dioctyl sulphate; sulphate arsenic; desertified dufenol; delmopinol; ': alcohol ° and other piperidinyl derivatives a nicotinic acid preparation; a sulfite acid salt; and a mixture of any of the foregoing. 2.16 Any of the above compositions comprises a whitening agent. ❹ 2.17 Any of the above compositions comprises a whitening active whitening agent selected from the group consisting of peroxides, metal chlorites, perborates, percarbonates, peroxyacids, hypoxides, and combinations thereof. ' 2.18 Any of the above compositions further comprises hydrogen peroxide or a source of hydrogen peroxide such as urea peroxide or a peroxide salt or complex (for example, peroxyphosphate, peroxycarbonate, perborate, peroxydecanoate) Or persulfate; for example, calcium phosphate peroxide, sodium perborate, sodium percarbonate, sodium peroxyphosphate and potassium persulfate), or a hydrogen peroxide polymer complex such as hydrogen peroxide _polyethylene σ pyrrolidone Polymer complex. 9 201006503 2.19 can be effectively applied to any of the above-mentioned compositions of the oral cavity, such as the oral device of any device 3, which can (i) reduce the formation of cavities; (9) reduce, repair or inhibit early enamel lesions, Determination of photoexcited fluorescence (QLF) or electrocautery measurement (ecm), (111) reducing or inhibiting demineralization of teeth and promoting remineralization to reduce tooth hypersensitivity; (V) reducing or inhibiting gingivitis; Promote L-cavity ulceration or wound riding; (vii) reduce the relative concentration of arginine-dissolving bacteria; (10) inhibit oral cavity, and biofilm formation; (X) rise after eating confectionery And / ΡΗ at a level of at least ρ Η 5.5: (10) reduce the accumulation of tartar treatment, ease or reduce dry mouth; _) clean teeth and mouth. (d) reduce rot to whiten teeth; (d) teeth immune to the bacterium; and / or (xvii) Promote the inclusion of cardiovascular disease, for example by reducing the likelihood of systemic infection through the oral tissue. 2.2〇 - The species that is obtained or obtained by any of the above-mentioned objects. Further, the present invention further provides that it is difficult to provide (device 3 Q), the system-material oral device 'the first material is coated with any of the following devices: · δ 3.1 device 3. Wherein the device is a head having an attachment 3.2 device 3, wherein one of the compositions is a coating of 13. device U or 3.2 of the paper product aw. Λ 201006503 3.4 Device 3.0 wherein the device is a toothpick. 3.5 Apparatus 3.0 wherein the apparatus is a tongue cleaner ° 3.6 apparatus 3.5 wherein the tongue cleaner comprises a surface for cleaning the tongue, the surface being coated with one of the compositions 1.0-2.19. 3.7 Device 3.5 wherein the device is a mouthguard. 3.8 Apparatus 3·0 or 3.7 wherein the apparatus is an orthodontic device such as a solid positioner. 3.9 Any of the devices 3.0-3.7 is made by the method 4 or method 5 described below. The invention also encompasses the method 4, which is a method for manufacturing an oral device comprising: 1. dissolving a bio-polymer or a monomer thereof in a solvent to form a solution; 2. using a basic amino acid Mixing into the solution; ❿ 3. removing the device from the solution to apply the solution to the device; and 4. evaporating the solvent. The device is preferably insoluble or substantially insoluble in the solvent. The invention also encompasses method 5, which is a method of making an oral device comprising: 1. blending a basic amino acid with a monomer that is polymerizable to form a biodegradable polymer; 2. Soak the device into the mixture; 201006503 3. Remove the device from the mixture; and 4. Treat the cleaning device under conditions that induce monomer polymerization to form a bioerodible polymer. The present invention further provides a method (method 6) which comprises causing a person in need thereof to contain an oral composition of (tetra) amino acid, such as any device 3.0-3.9, which can achieve (i) reduce or inhibit the formation of a tooth (9) reducing, repairing, or inhibiting early stromal lesions, such as by quantitative photoexcited fluorescence (QLF) or electrical surfacetooth measurement (ECM); (10) reducing or inhibiting demineralization of teeth and promoting remineralization (iv) reduce tooth hypersensitivity; (v) reduce or inhibit gingivitis; (vi) promote oral ulcer or wound healing; (vU) reduce acid-producing bacteria concentration; (Viii) increase arginine-dissolving bacteria Relative concentration; (10) inhibiting the formation of microbial biofilm in the oral cavity: (8) increasing and/or maintaining the tartar pH at a pH of at least 5.5 after eating the confection; (10) reducing the accumulation of tartar; (xii) treating, alleviating or reducing the dryness of the mouth; Xm) cleans teeth and mouth; (xiv) reduces corrosion; (xv) whitens teeth; (xvi) teeth are immune to cariogenic bacteria; and/or (xvii) promotes cardiovascular health, for example by hail Low likelihood of systemic infection through the oral tissue. The invention further comprises a basic amino acid for the manufacture of a dental device such as any of the devices 3.0-3.9 described above, such as the manufacturing method described above, such as method 4 or 5' or the method described above, such as method 6. use. Other embodiments of the invention will be apparent to those of ordinary skill in the art. 12 201006503 [Embodiment] A bioerodible polymer as described herein is a polymer which can be degraded by violent mouth. Degradation can occur when the material comes into contact with the oral cavity = for example. The friction between the polymer and the σ cavity can also cause degradation. Depending on the thickness of the polymer, it is only degraded with the surface of the oral cavity. J take the mouth 、-”有效量,,係足以在口腔内產生所欲治療或預防效應 而不造成例如刺激或過敏反應之不良副作用的數量。… 除非另有明示’否則此處所述驗性胺基酸包 離驗或鹽類之驗性胺基酸。 / 用於口腔的器具已為本技術領域中所習知,以及包括 例如牙刷、到舌器、牙線、牙籤、護口膠,以及牙齒^正 裝置例如牙套和is位ϋ。用於口助的器具並不僅偈限於 清潔和牙賴正裝置。其他器具包括可被用於口腔内之設 計的物件,例如奶嘴(亦稱為安慰器或纾緩器),以及幼兒和 嬰兒的㈣玩具例如咬牙環。其他器具包括非設計用於口 腔但人類可能將該物件含於口中的物件,例如筆和鉛筆。 此類器具雖然可用鹼性胺基酸處理例如表面塗;,但 較佳為直接將鹼性胺基酸併入該器具内以避免需重複地處 理。此可藉由以包含鹼性胺基酸的生物可蝕性聚合物塗佈 該器具而完成,或以相同方法製造該器具。由於聚合物的 表面係暴露細㈣,可將聚合物表面祕性胺基酸 釋放至口腔内。由於聚合物表面在例如正常用於口腔内時 被腐蝕,因此需供應釋入口腔内的額外鹼性胺基酸。 13 201006503 亦可使用多孔材料而直接將鹼性胺基酸併入該器具 内。該器具可自多孔材料製造,或可被其塗佈。通常,^ 材料含存在鹼性胺基酸於其中的孔隙。胺基酸可在使用該 器具例如置於口腔内時被釋出。若孔隙釋出其所含之胺基 酸,則該多孔材料可藉由暴露該鹼性胺基酸來處理以再充 填該孔隙。因此,該鹼性胺基酸可從該孔隙被釋出或駐留 其内。 用於製造使用於口腔内之器具的方法以及製造其之組 成物亦為本技術領域中所熟知的。本發明亦預期以包含生◎ 物可蝕性聚合物及鹼性胺基酸的組成物製造此類器具,或 具有鹼性胺基酸的多孔支架。 生物可蚀性聚合物已為本技術領域中具有通常知識者 所熟知,以及包括聚(乳酸)、聚(乙醇酸)和共聚物;聚二〇号 酮、聚(麵胺酸乙酯)、聚(經基丁酸酯)、聚(經基戊酸酯)和 共聚物;聚己内酯、聚酸酐、聚(原酸酯)、聚(亞胺基碳酸 酯)、聚酯醯胺類、聚酯胺類、聚氰丙烯酸酯類、聚磷腈類, 共聚物及其他脂族聚酯,或其適當共聚物包括聚-L-乳酸和 聚ε -己内酯的共聚物;混合物、共聚物,及其組合。其他 有用聚合物亦包括聚丙烯酸酯類、聚丙歸酸曱酯類、聚胺 基曱酸酯類、聚烯烴類、聚齒化乙烯類、聚齒化亞乙烯類、 聚乙烯醚類、芳香聚乙烯類、聚丙烯腈類、樹脂、聚矽氧 烷類、環氧樹脂和聚四氟乙烯。其他有用聚合物包括或基 於血纖維蛋白、膠原蛋白、葡萄胺聚醣 (glycosoaminoglycan)、寡酷和多醣、敕骨素、填酯質、石粦 14 201006503 酸膽鹼、聚葡萄胺糖、褐藻酸酯、纖維蛋白(fibring)、纖維 蛋白原、纖維素、殿粉、葡聚糖、糊精、玻尿酸、肝素和 彈性蛋白。該聚合物亦可為一多嵌段共聚物例如建構自乙 交酯、丙交酯、6 -己内酯和聚乙二醇的基礎單位。有用的 聚合物亦包括聚(酯-醯胺)聚合物或類似物,其以白胺酸、 苯丙胺酸及/或精胺酸為基礎’選擇地具有一或多種二元醇 類和一或多種二曱酸類。 ❻ 例如從單體形成此類聚合物的方法已為本技術領域中 所熟知。誘發聚合的方法已為本技術領域中所習知,例如 溶解於溶劑内、暴露於包括可見和UV輻射之輻射,以及 熱處理。 多孔支架為本技術領域中所習知,以及包括塑膠、陶 究和其他材料。塑膠及其形成為本技術領域中所熟知,以 及包括聚乙烯、聚曱基丙烯酸甲酯、聚胺基曱酸酯、聚乙 烯對苯二甲酸酯、聚丙烯、聚苯乙烯、聚醯胺、生物塑膠 Ο 和生物可降解塑膠。孔隙的大小極為重要其原因為小孔隙 度無法吸收和釋出該鹼性胺基酸,以及大孔隙將需持續的 負载。在本發明的一個具體實施例中,該孔隙的直徑平均 為從約10微米至約500微米例如約1〇微米、20微米、3〇 微米、40微米、50微米、60微米、70微米、80微米、9〇 微米、100微米、2〇〇微米、300微米或400微米直徑。 可被用於本發明組成物内的鹼性胺基酸不僅包括天然 驗性胺基酸例如精胺酸、離胺酸和組胺酸亦包括分子内具 有翹基和胺基的任何鹼性胺基酸。因此’鹼性胺基酸包括 15 201006503 但不侷限於精胺酸、離胺酸、瓜胺酸、鳥胺酸、肌酸、組 胺酸、二胺基丁酸、二胺基丙酸,其鹽類或其組合。在一 特定具體實施例中,該鹼性胺基酸係選自精胺酸、瓜胺酸 和鳥胺酸,較佳為精胺酸例如L-精胺酸。- "effective amount," is an amount sufficient to produce the desired therapeutic or prophylactic effect in the oral cavity without causing adverse side effects such as irritation or allergic reactions.... Unless otherwise stated, otherwise the aristomic acid pack described herein Tests or salts of test amines. / Appliances for the oral cavity are well known in the art and include, for example, toothbrushes, tongues, floss, toothpicks, mouthguards, and teeth. Devices such as braces and iss. Devices for mouth assistance are not limited to cleaning and squeezing devices. Other devices include items that can be used in the design of the mouth, such as pacifiers (also known as placebos or relief). (4), as well as toys for infants and babies such as teething. Other appliances include items that are not designed for the mouth but that humans may include in the mouth, such as pens and pencils. These devices can be treated with basic amino acids. For example, surface coating; however, it is preferred to incorporate the basic amino acid directly into the device to avoid repeated treatment. This can be by coating the device with a bioerodible polymer comprising a basic amino acid. Finishing, or manufacturing the device in the same way. Since the surface of the polymer is exposed to fine (d), the polymer surface amino acid can be released into the oral cavity. Since the polymer surface is corroded, for example, when used normally in the oral cavity, It is therefore necessary to supply an additional basic amino acid in the release chamber. 13 201006503 A basic amino acid can also be directly incorporated into the device using a porous material. The device can be manufactured from or can be coated with a porous material. Typically, the material contains pores in which the basic amino acid is present. The amino acid can be released when the device is placed, for example, in the oral cavity. If the pores release the amino acid contained therein, the porous The material may be treated by exposing the basic amino acid to refill the pores. Thus, the basic amino acid may be released or resident from the pores. Method for making an appliance for use in the oral cavity And the compositions from which they are made are also well known in the art. The present invention also contemplates the manufacture of such devices with a composition comprising a bioerodible polymer and a basic amino acid, or a basic amine group. Acid porous Bioerodible polymers are well known to those of ordinary skill in the art, and include poly(lactic acid), poly(glycolic acid) and copolymers; polydimethyl ketones, poly(ethyl face) ), poly(pyridinate), poly(pivalate) and copolymer; polycaprolactone, polyanhydride, poly(orthoester), poly(iminocarbonate), polyester oxime Amines, polyesteramines, polycyanoacrylates, polyphosphazenes, copolymers and other aliphatic polyesters, or suitable copolymers thereof, include copolymers of poly-L-lactic acid and poly-ε-caprolactone; Mixtures, copolymers, and combinations thereof. Other useful polymers also include polyacrylates, polyacrylic acid esters, polyamine phthalates, polyolefins, polydentate vinyls, polydentate vinylenes. Classes, polyvinyl ethers, aromatic polyethylenes, polyacrylonitriles, resins, polyoxyalkylenes, epoxies and polytetrafluoroethylene. Other useful polymers include or based on fibrin, collagen, glucosamine Glycos (glycosoaminoglycan), oligosaccharides and polysaccharides, scutellaria, sulphate, sarcophagus 1 4 201006503 Acid choline, polyglucosamine, alginate, fibring, fibrinogen, cellulose, house powder, dextran, dextrin, hyaluronic acid, heparin and elastin. The polymer may also be a multi-block copolymer such as a base unit constructed from glycolide, lactide, 6-caprolactone, and polyethylene glycol. Useful polymers also include poly(ester-guanamine) polymers or analogs which, based on leucine, phenylalanine and/or arginine, selectively have one or more glycols and one or more Diterpenic acid.方法 Methods for forming such polymers from monomers, for example, are well known in the art. Methods of inducing polymerization are well known in the art, such as dissolution in a solvent, exposure to radiation including visible and UV radiation, and heat treatment. Porous scaffolds are well known in the art and include plastics, ceramics, and other materials. Plastics and their formation are well known in the art and include polyethylene, polymethyl methacrylate, polyamino phthalate, polyethylene terephthalate, polypropylene, polystyrene, polydecylamine. , bioplastics and biodegradable plastics. The size of the pores is extremely important because small pores cannot absorb and release the basic amino acids, and large pores will require a constant load. In a particular embodiment of the invention, the pores have an average diameter of from about 10 microns to about 500 microns, such as about 1 inch, 20 microns, 3 microns, 40 microns, 50 microns, 60 microns, 70 microns, 80. Micron, 9 〇 micron, 100 micron, 2 〇〇 micron, 300 micron or 400 micron diameter. The basic amino acid which can be used in the composition of the present invention includes not only natural organic amines such as arginine, lysine and histamine but also any basic amine having a warp group and an amine group in the molecule. Base acid. Thus 'alkaline amino acid includes 15 201006503 but is not limited to arginine, lysine, citrulline, ornithine, creatine, histidine, diaminobutyric acid, diaminopropionic acid, Salt or a combination thereof. In a particular embodiment, the basic amino acid is selected from the group consisting of arginine, citrulline and ornithine, preferably arginine such as L-arginine. 鹼性胺基酸在其游離鹼或鹽型聚合之前或期間可被加 入該生物可蝕性聚合物。如此處所述,提及一鹼性胺基酸 時亦包括其鹽類。由於本發明的組成物和裝置擬被用於口 腔内,因此用於本發明之鹽類在提供的數量和濃度之下必 需對於該用途為安全。適當鹽類包括在提供的數量和濃度 之下通常被視為生理上可接受之醫藥上可接受鹽的技術中 習知鹽類。生理上可接受鹽包括衍自醫藥上可接受無機或 有機酸類或鹼類者,例如可形成生理上可接受陰離子之酸 的酸加成鹽類例如鹽酸鹽或溴化鹽,以及可形成生理上可 接受陽離子之鹼的鹼加成鹽,例如衍自鹼金屬如鉀和鈉或 鹼土金屬如鈣和鎂者。可利用本技術領域中已知的標準程 序獲侍生理上可接受鹽,例如藉由一足量鹼性化合物如胺 與可產生一生理上可接受陰離子的適當酸之反應。 、本發明組成物包含—有效量驗性胺基酸。因此,該 組成物可包含從約1%至約5G%重量比雜性胺基酸,例如 約 1、2、3、4、5、10、15、20、25、30、35、40 或 45%。 在-個具體實施例中,該驗性胺基酸可溶解於聚合物 内。在-較佳㈣實施例巾,紐性胺基酸不溶於該聚合 物内。若胺基酸為不可溶時,該胺基酸較佳為具有足夠小 的粒度而使其用於口㈣時不造成口腔的刺激。該胺基酸 201006503 較佳為均勻分佈於該聚合物内。 在一個具體實施例中該聚合物係一陰離子聚合物,例 如聚羧酸鹽聚合物如丙烯酸鹽聚合物或共聚物,其中兮驗 性胺基酸與聚合物内的羧酸基團形成鹽。 、^ 在本發明的一個具體實施例中’該生物可蝕性聚合物 或多孔支架選擇性地包含-有效量的氟化物或氟離子源。 本組成物内可使用廣泛不同的氟離子產生材料作為可溶性The basic amino acid can be added to the bioerodible polymer before or during its free base or salt type polymerization. As mentioned herein, reference to a basic amino acid also includes salts thereof. Since the compositions and devices of the present invention are intended to be used in the oral cavity, the salts used in the present invention must be safe for this use in the amounts and concentrations provided. Suitable salts include the well-known salts of the art which are generally considered to be physiologically acceptable pharmaceutically acceptable salts under the amounts and concentrations provided. Physiologically acceptable salts include those derived from pharmaceutically acceptable inorganic or organic acids or bases, such as acid addition salts such as hydrochlorides or bromides which form a physiologically acceptable anionic acid, and which form physiological Base addition salts of bases which accept cations, such as those derived from alkali metals such as potassium and sodium or alkaline earth metals such as calcium and magnesium. Physiologically acceptable salts can be obtained by standard procedures known in the art, for example by reaction of a sufficient amount of a basic compound such as an amine with a suitable acid which produces a physiologically acceptable anion. The composition of the invention comprises an effective amount of an amino acid. Thus, the composition may comprise from about 1% to about 5G% by weight of the fatty amino acid, for example about 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40 or 45 %. In a particular embodiment, the in situ amino acid is soluble in the polymer. In the preferred embodiment of the invention, the neotide acid is insoluble in the polymer. If the amino acid is insoluble, the amino acid preferably has a particle size small enough that it does not cause irritation to the mouth when it is applied to the mouth (iv). The amino acid 201006503 is preferably uniformly distributed within the polymer. In one embodiment the polymer is an anionic polymer, such as a polycarboxylate polymer such as an acrylate polymer or copolymer wherein the test amine acid forms a salt with a carboxylic acid group within the polymer. In a particular embodiment of the invention, the bioerodible polymer or porous scaffold selectively comprises an effective amount of a fluoride or fluoride ion source. A wide variety of fluoride ion-generating materials can be used as soluble in the composition. 氟化物源。適當氟離子產生材料的實例請參考授予Briner 等人的美國專利案號3,535,42丨;授予Parran,Jr.等人的美國 專利案號4,885,155錢授予Widder f人的美國專利案號 3,678,154,藉由引述將其併入於此。代表性氟離子源包括 但不侷限於氟化亞錫、氟化鈉、氟化鉀、單氟磷酸鈉、氟 矽酸鈉、氟矽酸銨、氟化胺、氟化銨,及其組合。在某些 具體實例中,該氟離子源包括氟化亞錫、氟化鈉、單氣^ 酸鈉,及其混合物。 在本發明的另一具體實施例中,該生物可触性聚合物 或多孔支架可選擇性地包含—防腐劑或抗微生物劑以進一 步增=性絲酸的有益效應,該防制或抗微生物係選 自二氯沙:草本萃取物和精油(例如迷迭香轉物、瑞香紛、 薄荷醇二桉葉醇、甲基水揚酸);雙胍抗菌劑(例如沙威隆、 阿立西疋(alexidine)或奥替尼咬(〇cten^^ne));季錄化合物 (例如亂化録峨基处啶);苯酚殺菌劑;海克西定 (heXetidine);優碘;地莫匹醇(dehnopinol) ; saliflU〇r :金屬 離子(例如辞鹽如檸檬酸鋅);血根鹼(sanguinarine) ;蜂膠; 17 201006503 及其組合。 當塗佈於一器具上時,該生物聚合物或多孔支架較佳 為具有不妨礙該器具使用的足夠薄度,但具有使其後正常 使用之器具上例如使用3、4、5、1〇、ι5、2〇、25、3〇、6〇 或90次之後保留足夠量聚合物的厚度。該器具的正常使用 將視特定器具而定。該生物聚合物的厚度可從約〇丨微米至 約3000微米’約1微米、5微来' 1〇微米、%微米、% 微米、100微米、250微米、500微米、1000微米、2〇〇〇微 米或約3000微米的厚度。塗佈層的厚度將視特定器具而定。© 本發明組成物亦可含有香料。可被用於本發明實務的 調味劑包括,但不侷限於精油和各種的調味醛類、酯類、 醇類,以及類似材料。精油的實例包括留蘭香油、薄荷油、 冬清油、黃樟油、丁香油、鼠尾草油、桉葉油、馬鬱蘭油、 肉桂油、檸檬油、萊姆精油、葡萄柚油和橙油。此類化學 物質亦可使用甲醇、香芹酮(carvone)和大茴香腦 (anethole)。本發明組成物亦含有著色劑。香料和著色劑的 用途為幫助測定該支架是否含該胺基酸,或生物可蝕性聚❹ 合物的被降解程度。 本發明組成物亦可被用作為口腔内的黏著劑,例如與 牙齒矯正牙套使用之牙套用黏著劑。本發明組成物亦可用 作為製造器具的勒著劑,例如黏著牙刷頭至其刷柄。本發 明亦可被用作為牙科用密封劑,例如保護塗料。 實例1 以包含40%重量比L_精胺酸和香料如薄荷的生物可蝕 201006503 性聚合物㈣適用於_性運㈣ ==:降解而“精胺酸釋八口腔:二= 修補或抑制早期鞋螂質病變;減 少或抑制^的去礦化及促進再魏;減少或抑制齒銀 炎;降低產酸_丨農度;增加精㈣溶解菌的相對濃度; 以及使牙垢PH上升及/或維持在至少pH $ 5的程度。重複 使用該護口料進-步降_聚合物,當動膠不再具有 薄荷味道時使用者可確認聚合物已被完全降解。 實例2 以具有50微米平均孔徑的多孔塑膠支架製造奶嘴。將 該奶嘴浸潰於包含精胺酸碳酸氫鹽的清潔溶液内,並且該 精胺酸碳酸氫鹽被吸收入孔内。 實例3Fluoride source. For an example of a suitable fluoride ion-generating material, reference is made to U.S. Patent No. 3,535,42, issued to the name of the entire disclosure of U.S. Pat. 154, which is incorporated herein by reference. Representative fluoride ion sources include, but are not limited to, stannous fluoride, sodium fluoride, potassium fluoride, sodium monofluorophosphate, sodium fluoroantimonate, ammonium fluoroantimonate, amine fluoride, ammonium fluoride, and combinations thereof. In some embodiments, the fluoride ion source comprises stannous fluoride, sodium fluoride, sodium monosodium sulfate, and mixtures thereof. In another embodiment of the invention, the biotactable polymer or porous scaffold may optionally comprise a preservative or antimicrobial agent to further enhance the beneficial effects of the sex silk, the control or antimicrobial It is selected from the group consisting of dichlorin: herbal extracts and essential oils (such as rosemary, scented menthol, menthol, and methyl salicylate); biguanide antibacterials (such as Shaweilong, Alixidin) (alexidine) or octenidine bite (〇cten^^ne)); seasonally recorded compounds (eg, pyridine); phenol bactericide; hexetidine; iodine; delmopinol (dehnopinol); saliflU〇r: metal ion (for example, salt such as zinc citrate); sanguinarine; propolis; 17 201006503 and combinations thereof. When applied to an implement, the biopolymer or porous scaffold preferably has a sufficient thickness that does not interfere with the use of the device, but has an apparatus for normal use thereafter, for example, 3, 4, 5, 1 . A sufficient amount of polymer is retained after ι 5, 2 〇, 25, 3 〇, 6 〇 or 90 times. The normal use of the appliance will depend on the particular appliance. The biopolymer may have a thickness of from about 〇丨 micron to about 3000 micron 'about 1 micron, 5 micro', 1 micron, % micron, % micron, 100 micron, 250 micron, 500 micron, 1000 micron, 2 〇〇. 〇 microns or a thickness of about 3000 microns. The thickness of the coating layer will depend on the particular appliance. © The composition of the present invention may also contain a fragrance. Flavoring agents that can be used in the practice of the present invention include, but are not limited to, essential oils and various flavoring aldehydes, esters, alcohols, and the like. Examples of essential oils include spearmint oil, peppermint oil, winter oil, sassafras oil, clove oil, sage oil, eucalyptus oil, marjoram oil, cinnamon oil, lemon oil, lime oil, grapefruit oil and orange oil. Methanol, carvone and anethole can also be used for such chemicals. The compositions of the present invention also contain a colorant. The use of perfumes and colorants is to aid in determining whether the scaffold contains the amino acid, or the degree of degradation of the bioerodible polyconjugate. The composition of the present invention can also be used as an adhesive in the oral cavity, for example, an adhesive for dental mouthpieces for use with orthodontic braces. The composition of the present invention can also be used as a tamper for the manufacture of articles, for example, by adhering the brush head to its handle. The invention can also be used as a dental sealant, such as a protective coating. Example 1 Biodegradable 201006503 polymer containing 40% by weight of L_arginine and perfume such as peppermint (4) is suitable for _sexual transport (4) ==: degradation and "arginine acid release eight oral: two = repair or inhibition Early shoe enamel lesions; reduce or inhibit demineralization and promote re-Wei; reduce or inhibit dental calculus; reduce acid production _ 丨 度 ;; increase the relative concentration of fine (4) lysing bacteria; and increase tartar PH and / Or maintain it to a level of at least pH 5. Repeat the use of the mouth-feeding-step-polymer, the user can confirm that the polymer has been completely degraded when the gelatin no longer has a mint taste. Example 2 has 50 microns A porous plastic stent having an average pore diameter produces a teat. The teat is immersed in a cleaning solution containing arginine hydrogencarbonate, and the arginine hydrogencarbonate is absorbed into the pores. 將實例2的奶嘴給予嬰兒正常使用,即吸和吮。當嬰 兒吸和吮該奶嘴時’精胺酸碳酸氳鹽被釋入口腔内而抑制 口腔内微生物生物膜的形成。 實例4 將實例3的經使用奶嘴浸潰入包含精胺酸碳酸氫鹽的 清潔溶液内。 實例5 以包含精胺酸及顏色如紅色的生物可姓性聚合物塗佈 透明牙刷頭。將鬃毛貼附至頭部,及使該頭部連接一把柄。 201006503 口腔内使用該牙刷時該聚合物可被降解而釋出精胺酸。當 該頭部不再呈紅色時使用者則得知需更換該頭部或牙刷。 【圖式簡單說明】 無 【主要元件符號說明】 無The nipple of Example 2 was given to the baby for normal use, i.e., sucking and rubbing. When the baby sucks and licks the nipple, the arginine strontium carbonate is released into the cavity to inhibit the formation of microbial biofilm in the oral cavity. Example 4 The used nipple of Example 3 was dipped into a cleaning solution containing arginine hydrogencarbonate. Example 5 A transparent toothbrush head was coated with a biodegradable polymer comprising arginine and a color such as red. Attach the bristles to the head and attach the head to a handle. 201006503 The polymer can be degraded to release arginine when the toothbrush is used in the mouth. When the head is no longer red, the user knows that the head or toothbrush needs to be replaced. [Simple diagram description] None [Main component symbol description] None 20 201006503 發明糞利說明書 98J920 201006503 Invention Manure Guide 98J9 (本說明書格式、順序,請勿任意更動,※記號部分請勿填寫) ※申請案號: ※申請曰: 分類: 、發明名矛冉.(中文/英文) 組成物及裝置(二) COMPOSITIONS AND DEVICES 二、中文發明摘要: 本發明提供包含鹼性胺基酸的口腔器具及製造此類11 具的組成物,以及製造和使用此類器具的方法。 ©三、英文發明摘要: The present invention provides oral instruments comprising a basic amino acid, to compositions for making such instruments, and to methods of making and using such instruments. 1 2〇1〇〇65〇3 七、申請專利範圍: • 一種含有游離或鹽型鹼性胺基酸之組成物,該鹼性胺 基酸係被後入生物可餘性聚合物。(Please do not change the format and order of this manual, please do not fill in the ※ part) ※Application number: ※Application曰: Classification: Invented name spear. (Chinese/English) Composition and device (2) COMPOSITIONS AND DEVICES II. Abstract of the Invention: The present invention provides an oral appliance comprising a basic amino acid and a composition for the manufacture of such an article, and a method of making and using such an appliance. ©3, English Abstract: The present invention provides oral instruments comprising a basic amino acid, to compositions for making such instruments, and to methods of making and using such instruments. 1 2〇1〇〇65〇3 VII. : A composition containing a free or salt-type basic amino acid which is incorporated into a biorenewable polymer. 2.如申請專利範圍第1項之組成物,其中該生物可蝕性 聚合物係選自聚(乳酸)、聚(乙醇酸)和共聚物;聚二啐 _、聚(麩胺酸乙酯)、聚(羥基丁酸酯)、聚(羥基戊酸酯) 和共聚物;聚己内酯、聚酸酐、聚(原酸酯)、聚(亞胺基 碳酸酯)、聚酯醯胺類、聚酯胺類、聚氰丙烯酸酯類、 聚磷腈類,共聚物及其他脂族聚酯,或其適當共聚物包 括聚-L-乳酸和聚ε-己内酯的共聚物、血纖維蛋白、膠 原蛋白、葡萄胺聚畴(glycosoaminoglycan)、寡醋、多 聽、軟骨素、聚葡萄胺糖(chitosan)、褐藻酸酯、纖維 蛋白(fibring)、纖維蛋白原、纖維素、澱粉、葡聚糖、 糊精、玻尿酸、肝素、彈性蛋白;多嵌段共聚物例如建 構自乙交酯、丙交酯、ε _己内酯的基礎單位;以及聚 乙一醇和聚(酯_醯胺)聚合物或類似物,其以白胺酸、笨 丙胺酸及/或精胺酸為基礎,選擇地具有一或多種二元醇 類和一或多種二甲酸類。 3 _ ’ 種組成物,其包括具有孔隙之支架及存在該孔隙間 之鹼性胺基酸。 4.如申請專利範圍第3項之組成物,其中該支架係塑膠。 申請專利範圍第3或4項之組成物,其中該支架係 選自聚乙烯、聚甲基丙烯酸曱酯、聚胺基甲酸酯、聚乙 21 201006503 烯對苯二甲酸酯、聚丙烯、聚苯乙烯、聚醯胺類、生物 塑膠、生物可降解塑膠,及其組合。 6. 如申請專利範圍第3〜5項中任一項之組成物,其中該 鹼性胺基酸可逆地存在於該孔隙間。 7. 如上述申請專利範圍中任一項之組成物,其中該鹼性 胺基酸係精胺酸、離胺酸、瓜胺酸、鳥胺酸、肌酸、 組胺酸、二胺基丁酸、二胺基丙酸,其鹽及/或其組 合。 8. 如上述申請專利範圍中任一項之組成物,其中該鹼性 胺基酸具有L-構型。 9. 如上述申請專利範圍中任一項之組成物,其中該鹼性 胺基酸係精胺酸。 10. 如上述申請專利範圍中任一項之組成物,其中該驗性 胺基酸係L-精胺酸。 11. 如上述申請專利範圍中任一項之組成物,其包含鹽型 的鹼性胺基酸。 12. 如上述申請專利範圍中任一項之組成物,其包含精胺 酸磷酸鹽。 13. 如上述申請專利範圍_任一項之組成物,其包含精胺 酸鹽酸鹽。 14. 如上述申請專利範圍中任一項之組成物,其包含一精 22 201006503 胺酸鹽及一陰離子聚合物。 15. 如上述申請專利範圍令任一項之組成物,其包含精胺 酸碳酸氫鹽。 16. 種裝置,其包括使用如申請專利範圍第1〜15項中 任一項之組成物塗佈之器具。 魯 ❿ 17. ^請專利範圍第16項之裝置,其中該器具係包括 具有鬃毛貼附其頭部的牙刷。 A ;=專2圍第17項之裝置,其中該鬃毛被如申 身專利範圍心七項中任―項之組成物塗佈。 19.如申請專利範圍帛17或18項 2〇如申請專利範圍第W項中任-項之組成物=破 h如中請專利範圍第16項之裝置,其_該器具係牙藏。 • ^申請專利範圍第16項之裝置 清潔器。 Τ Μ器具係舌苔 22. $申請專利範圍第21項之裝置,其中該 f 一清潔舌頭的表面,該表面係以如申二主專口二^包 1〜15項中任一項之組成物塗佈。申巧專利範圍第 3’如申請專利範圍第16項之 膠。 置其中該器具係護口 ‘如申請專利範圍第16項之裝置 。 場正裝置。 、中該器具係牙齒 23 201006503 > 、 25. —種方法,复可 修補或抑制早期二7或抑制姓牙的形成;⑼減少、 灿啦歧發勞光 牙齒的去魏及促進二J::,咸少抑制 f少(或=炎,促進-内潰牙:::的:) ; (viii) —目對/辰度,⑻抑制口腔内微生物生物膜的形成 乙甜食之後上升及/或維持牙垢pH在至少pH 5 5的程 度;〇d)減少牙垢的積聚;(xii)治療、緩和或減少口腔 乾燥;(xiii)清潔牙齒和口腔;(xiv)減少腐蝕;(xv)使 牙齒變白;(xvi)使牙齒對致麵菌免疫;及/或(χνϋ)促進 包括心血管的身體健康,例如藉由降低經由口腔組織全 身性感染的可能性’其包含使用一 口腔裝置’該裝置包 含鹼性胺基酸,其係根據個人的需要。 26. 如申請專利範圍第 _/、,_ ,、 種鹼性胺基酸於製造牙齒裝置之用 如申請專利範圍第25項之方法,其中該裝置係一種 如申請專利範圍第16〜24項中任一項之裝置。 27. 途 T至慨*丨王妝麥Η又/八衣巧•菌衷置之用述'^ 28.如申請專利範圍第27項之用途,其中該裝置係 如申請專利範圍第16〜24項中任一項之裝置。 24 201006503 四、指定代表圖·· (一) 本案指定代表圖為:第(無)圖。 (二) 本代表圖之元件符號簡單說明: 無 五、本案若有化學式時,請揭示最能顯示發明特徵的化學式: 無2. The composition of claim 1, wherein the bioerodable polymer is selected from the group consisting of poly(lactic acid), poly(glycolic acid), and copolymer; polydioxane, poly(ethyl glutamate) ), poly(hydroxybutyrate), poly(hydroxyvalerate) and copolymer; polycaprolactone, polyanhydride, poly(orthoester), poly(iminocarbonate), polyester decylamine , polyesteramines, polycyanoacrylates, polyphosphazenes, copolymers and other aliphatic polyesters, or suitable copolymers thereof, including copolymers of poly-L-lactic acid and poly-ε-caprolactone, blood fibers Protein, collagen, glycosaminoglycan, vinegar, polysynthesis, chondroitin, chitosan, alginate, fibring, fibrinogen, cellulose, starch, Portuguese Glycan, dextrin, hyaluronic acid, heparin, elastin; multi-block copolymers such as basal units constructed from glycolide, lactide, ε-caprolactone; and polymerization of poly(ethylene glycol) and poly(ester amide) Or an analog based on leucine, albinoic acid and/or arginine, optionally having one or more Class and a diol or more dicarboxylic Acid. 3 _ ' Compositions comprising a scaffold having pores and a basic amino acid present between the pores. 4. The composition of claim 3, wherein the stent is a plastic. The composition of claim 3 or 4, wherein the support is selected from the group consisting of polyethylene, polymethyl methacrylate, polyurethane, polyethylene 21 201006503 olefin terephthalate, polypropylene, Polystyrene, polyamines, bioplastics, biodegradable plastics, and combinations thereof. 6. The composition of any one of claims 3 to 5, wherein the basic amino acid is reversibly present between the pores. 7. The composition according to any one of the preceding claims, wherein the basic amino acid is arginine, lysine, citrulline, ornithine, creatine, histidine, diamine Acid, diaminopropionic acid, salts thereof and/or combinations thereof. 8. The composition of any of the preceding claims, wherein the basic amino acid has an L-configuration. A composition according to any one of the preceding claims, wherein the basic amino acid is arginine. A composition according to any one of the preceding claims, wherein the testable amino acid is L-arginine. A composition according to any one of the preceding claims, which comprises a basic amino acid of a salt type. A composition according to any one of the preceding claims, which comprises arginine phosphate. 13. The composition of any one of the preceding claims, which comprises a arginine hydrochloride. 14. The composition of any of the preceding claims, comprising a fine 22 201006503 aminate and an anionic polymer. 15. A composition according to any of the preceding claims, which comprises arginine hydrogencarbonate. A device comprising an article coated with a composition according to any one of claims 1 to 15.鲁❿ 17. The device of claim 16 wherein the device comprises a toothbrush having a bristles attached to the head. A;=Special 2, the device of item 17, wherein the mane is coated with a composition of any of the seven items in the scope of the patent application. 19. If the scope of the patent application is 帛 17 or 18 2 〇 组成 组成 申请 申请 申请 = = = = = = 组成 组成 组成 组成 组成 组成 组成 组成 组成 组成 组成 组成 组成 如 如 如 如 如 如 如 如 如 如 如 如 如 如 如• ^Applicable to the device of the scope of the scope of the device cleaner. Τ Μ 系 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 22 Coating. Shen Qiao's patent scope is 3' as the glue of the 16th article of the patent application. Place the device as a protective device ‘as in the device of claim 16th. Field positive device. The device is a tooth 23 201006503 > , 25. A method that can repair or inhibit the formation of the early 2 or 7 or the formation of the last tooth; (9) reduce, the difference between the hair and the promotion of the tooth :, less salty inhibition f (or = inflammation, promotion - internal cavities::::); (viii) - eye / length, (8) inhibition of oral microbial biofilm formation after the rise of the sweets and / or Maintain tartar pH at least pH 5 5; 〇 d) reduce tartar accumulation; (xii) treat, alleviate or reduce dry mouth; (xiii) clean teeth and mouth; (xiv) reduce corrosion; (xv) change teeth (xvi) immunizing teeth against facets; and/or (χνϋ) promoting physical health including cardiovascular, for example by reducing the likelihood of systemic infection through the oral tissue 'which includes the use of an oral device' Contains a basic amino acid, depending on the individual's needs. 26. The method of claim _/, _, , a basic amino acid for use in the manufacture of a dental device, such as the method of claim 25, wherein the device is a patent application range 16 to 24 Any of the devices. 27. The way T to the generous * 丨 妆 妆 Η / / 八 八 八 八 八 菌 菌 菌 菌 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 28. 28. 28. 28. 28. 28. 28. 28. 28. 28. 28. 28. 28. 28. 28. 28. 28. 28. A device of any of the items. 24 201006503 IV. Designation of Representative Representatives (1) The representative representative of the case is: (No). (2) A brief description of the symbol of the representative figure: None 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: None
TW098103769A 2008-02-08 2009-02-06 Compositions and devices TWI367763B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2742808P 2008-02-08 2008-02-08

Publications (2)

Publication Number Publication Date
TW201006503A true TW201006503A (en) 2010-02-16
TWI367763B TWI367763B (en) 2012-07-11

Family

ID=40952699

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098103769A TWI367763B (en) 2008-02-08 2009-02-06 Compositions and devices

Country Status (15)

Country Link
US (1) US10130597B2 (en)
EP (1) EP2252254B1 (en)
JP (1) JP2011512335A (en)
CN (2) CN105030558A (en)
AR (1) AR070695A1 (en)
AU (1) AU2009212331B2 (en)
BR (1) BRPI0906452A2 (en)
CA (1) CA2706512C (en)
CO (1) CO6290716A2 (en)
MX (1) MX2010005004A (en)
MY (1) MY155410A (en)
RU (1) RU2519329C2 (en)
TW (1) TWI367763B (en)
WO (1) WO2009100275A2 (en)
ZA (1) ZA201003685B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011358606B2 (en) 2011-02-11 2014-10-30 Colgate-Palmolive Company Methods of analyzing plaque
US20120207806A1 (en) * 2011-02-15 2012-08-16 Lopesio Patricia M Multi-purpose dental appliance cleaner
EP2815870B1 (en) 2012-02-14 2019-09-11 Seidensha Electronics Co., Ltd Device for welding thermoplastic resin material
US9555057B2 (en) 2014-09-29 2017-01-31 The Research Foundation For The State University Of New York Compositions and methods for reducing cutaneous microbiome malodor
CN118267304A (en) * 2015-11-13 2024-07-02 宝洁公司 Dentifrice composition with improved fluoride uptake
CN105477688A (en) * 2015-12-08 2016-04-13 安徽天瑞塑业有限公司 Brush bristle improving oral ulcers and preparation process thereof
CN106620891A (en) * 2016-11-25 2017-05-10 北京刷新活力健康科技有限公司 A bioactive mineral powder intertooth healthcare floss brush and applications thereof
CN108852856A (en) * 2018-08-17 2018-11-23 柳州市人民医院 Application of the Epigallo-catechin gallate (EGCG) in orthodontic art
EP4014948A1 (en) * 2020-12-18 2022-06-22 Ivoclar Vivadent AG Composition for the remineralisation of teeth
JP7173259B1 (en) * 2021-10-06 2022-11-16 三菱ケミカル株式会社 Biodegradable resin composition, molded article and biodegradation method

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US452818A (en) * 1891-05-26 Sanitary plumbing
US3678154A (en) 1968-07-01 1972-07-18 Procter & Gamble Oral compositions for calculus retardation
US3535421A (en) 1968-07-11 1970-10-20 Procter & Gamble Oral compositions for calculus retardation
US3943241A (en) 1971-08-30 1976-03-09 General Mills, Inc. Cariostatic composition
US3932608A (en) 1971-08-30 1976-01-13 General Mills, Inc. Food composition
US3932605A (en) 1972-06-12 1976-01-13 Jaroslav Vit Dental treatment
US3988434A (en) 1972-08-07 1976-10-26 Schole Murray L Dental preparation
US4025616A (en) 1973-03-06 1977-05-24 The Procter & Gamble Company Oral compositions for plaque, caries and calculus retardation with reduced staining tendencies
US4100269A (en) 1973-06-28 1978-07-11 Lever Brothers Company Anticalculus dentifrice
US4022880A (en) 1973-09-26 1977-05-10 Lever Brothers Company Anticalculus composition
US3925543A (en) 1973-11-01 1975-12-09 Colgate Palmolive Co Antibacterial oral compositions containing preservative-antioxidants
US4011309A (en) 1975-01-20 1977-03-08 Marion Laboratories, Inc. Dentifrice composition and method for desensitizing sensitive teeth
US4064138A (en) 1975-11-12 1977-12-20 General Mills, Inc. Amino acid derivatives
ZA773318B (en) 1976-06-18 1978-04-26 I Kleinberg Means and method for improving natural defenses against caries
USRE31181E (en) 1976-06-18 1983-03-15 Means and method for improving natural defenses against caries
US4108981A (en) 1976-08-02 1978-08-22 Indiana University Foundation Alkaline oral compositions comprising aluminum and a carboxylic acid
US4108979A (en) 1976-08-02 1978-08-22 Indiana University Foundation Dentifrice preparations comprising aluminum and a compatible abrasive
US4042680A (en) 1976-08-02 1977-08-16 Indiana University Foundation Anticariogenic maloaluminate complexes
US4146607A (en) 1977-11-07 1979-03-27 Lever Brothers Company Synergistic anti-plaque mixture with tetradecylamine plus aluminum and/or zinc
US4160821A (en) 1978-02-27 1979-07-10 Johnson & Johnson Treatment for gingivitis
GB1573727A (en) 1978-05-19 1980-08-28 Colgate Palmolive Co Dentifrices
US4216961A (en) 1978-08-04 1980-08-12 Mcquillan Mary J Table baseball apparatus
US4225579A (en) 1979-02-27 1980-09-30 Israel Kleinberg Means and method for improving defenses against caries
US4339432A (en) 1979-06-20 1982-07-13 Lever Brothers Company Oral mouthwash containing zinc and glycine
US4269822A (en) 1979-07-20 1981-05-26 Laclede Professional Products, Inc. Antiseptic dentifrice
JPS5835965B2 (en) 1979-07-31 1983-08-05 ライオン株式会社 Oral composition
JPS5846483B2 (en) 1979-09-20 1983-10-17 ライオン株式会社 Oral composition
US4532124A (en) 1981-08-19 1985-07-30 Development Finance Corporation Of New Zealand Dental rinse
JPS58118509A (en) 1981-12-29 1983-07-14 Lion Corp Composition for oral cavity
US4885155A (en) 1982-06-22 1989-12-05 The Procter & Gamble Company Anticalculus compositions using pyrophosphate salt
EP0109359A1 (en) 1982-11-15 1984-05-23 Hawe-Neos Dental Dr. H. von Weissenfluh S.A. Improved toothpick
US4725576A (en) 1983-12-29 1988-02-16 Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing L-histidine and methods for use therefore
US4528181A (en) 1984-02-01 1985-07-09 Colgate-Palmolive Company Dentifrice containing dual sources of fluoride
US5334617A (en) 1984-03-19 1994-08-02 The Rockefeller University Amino acids useful as inhibitors of the advanced glycosylation of proteins
GB8411731D0 (en) 1984-05-09 1984-06-13 Unilever Plc Oral compositions
JPH0742219B2 (en) 1984-07-26 1995-05-10 ライオン株式会社 Oral composition
US4538990A (en) 1984-09-24 1985-09-03 Medical College Of Ga. Research Institute, Inc. Method of decreasing the permeability of a dental cavity
JPH0683640B2 (en) 1986-10-14 1994-10-26 味の素株式会社 Feed additive composition for ruminants
JPS63220804A (en) 1987-03-10 1988-09-14 土居 達郎 Toothbrush
GB8729564D0 (en) 1987-12-18 1988-02-03 Unilever Plc Oral compositions
US4986288A (en) * 1988-03-23 1991-01-22 Colgate-Palmolive Company Dental floss and picks
JP2608131B2 (en) 1989-03-14 1997-05-07 サンスター株式会社 toothbrush
JPH03178926A (en) 1989-12-06 1991-08-02 Shiseido Co Ltd Composition for oral cavity application
IL94294A (en) * 1990-05-04 1992-11-15 Hamivreshet Brush Factory Kibb Toothbrush
US5096700A (en) 1990-09-28 1992-03-17 The Procter & Gamble Company Halogenated aminohexanoates and aminobutyrates antimicrobial agents
SU1808293A1 (en) 1990-10-03 1993-04-15 Igor S Ivanov Tooth brush
KR100257842B1 (en) 1991-08-23 2000-06-01 질 시이 리차아드슨 Substained-release martrices
US5370865A (en) 1992-05-15 1994-12-06 Kao Corporation Composition for use in oral cavity
US5286480A (en) 1992-06-29 1994-02-15 The Procter & Gamble Company Use of N-acetylated amino acid complexes in oral care compositions
US5605756A (en) * 1993-09-14 1997-02-25 Gmz Holding Company Disposable toothbrush having mint flavored toothpaste composition bonded to bristles thereof
JPH07100153A (en) 1993-10-04 1995-04-18 Koki Bussan Kk Dental floss
EP0704533A1 (en) 1994-09-30 1996-04-03 Bayer Ag An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus
US5674067A (en) * 1995-06-07 1997-10-07 Masel; Richard I. Flavored orthodontic elastic band and method of treating orthodontic patient
IT1276689B1 (en) 1995-06-09 1997-11-03 Applied Pharma Res SOLID PHARMACEUTICAL FORM FOR ORAL USE
WO1997002802A1 (en) 1995-07-10 1997-01-30 Unilever N.V. Self-heating dentifrice
CA2184802C (en) 1995-10-10 2007-07-31 Karl-Heinz Bender Process for manufacture of imidazo benzodiazepine derivatives
US5762911A (en) 1996-03-05 1998-06-09 The Research Foundation Of State University Of New York Anti-caries oral compositions
US5716208A (en) * 1996-05-03 1998-02-10 Forman; David Orthodontic bracket with a water insoluble colored coating and the associated methods of manufacture and use
JPH105250A (en) 1996-06-21 1998-01-13 Kao Corp Toothpick
US6488961B1 (en) 1996-09-20 2002-12-03 Ethypharm, Inc. Effervescent granules and methods for their preparation
JP3720950B2 (en) 1997-05-30 2005-11-30 株式会社ダイショウー Shrinkable film and covering
US5906811A (en) 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
US5875798A (en) * 1997-09-23 1999-03-02 Advanced Medical Instruments, Inc. Therapeutic toothpick for treating oral and systemic diseases
US5922346A (en) 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US6805883B2 (en) 1998-03-12 2004-10-19 Mars, Incorporated Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide
US5997301A (en) 1998-10-20 1999-12-07 Linden; Lars Ake Treatment of tooth surfaces and substances therefor
US6166102A (en) * 1998-12-08 2000-12-26 Block Drug Company, Inc. Denture adhesive
US6436370B1 (en) * 1999-06-23 2002-08-20 The Research Foundation Of State University Of New York Dental anti-hypersensitivity composition and method
US6685928B2 (en) * 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
US20040038948A1 (en) 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
US20020081360A1 (en) 2000-12-27 2002-06-27 Andreas Burgard Salts of L-amino acid having improved taste and their preparation
US7247338B2 (en) * 2001-05-16 2007-07-24 Regents Of The University Of Minnesota Coating medical devices
RU2269973C2 (en) 2001-08-17 2006-02-20 СмитКлайн Бичем пи.эл.си. Strap for delivering matter intended for mouth care
ES2258134T3 (en) * 2002-01-18 2006-08-16 Nokia Corporation METHOD AND APPLIANCE FOR ACCESS CONTROL OF A WIRELESS TERMINAL DEVICE IN A COMMUNICATIONS NETWORK.
AU2003208761A1 (en) * 2002-02-21 2003-09-09 Amarin Development Ab A method for releasing nanosized particles of an active substance from a diffusion-controlled pharmaceutical composition for oral use
JP2004065707A (en) 2002-08-08 2004-03-04 Taro Kawasaki Pacifier for baby and little children and pacifier for baby and little children containing xylitol
CN1491608A (en) 2002-10-24 2004-04-28 上海民澍科技有限公司 Mouth freshening fragrant tooth-brush
CA2505889A1 (en) 2002-11-14 2004-06-03 Smithkline Beecham Corporation Controlled-dissolving polymeric device for the oral cavity
RU2238078C1 (en) 2003-01-21 2004-10-20 Чухаджян Ара Гарникович Therapeutic and prophylactic topical-destination facility in the form of self-sticking film for remineralization of solid dental tissues
US20070053848A1 (en) * 2003-08-26 2007-03-08 Stockel Richard F Antimicrobial materials for dental care applications
US7221753B2 (en) * 2003-03-04 2007-05-22 Verizon Business Global Llc Method and system for providing network interactive voice response with intelligent call routing integration
US20040220264A1 (en) * 2003-03-17 2004-11-04 Yu Ruey J Bioavailability and improved delivery of acidic pharmaceutical drugs
US8457082B2 (en) * 2003-06-06 2013-06-04 At&T Intellectual Property I, L.P. System and method for providing integrated voice and data services utilizing wired cordless access with unlicensed/unregulated spectrum
US8287843B2 (en) 2003-06-23 2012-10-16 Colgate-Palmolive Company Antiplaque oral care compositions
US20040258630A1 (en) 2003-06-23 2004-12-23 Boyd Thomas J. Antiplaque breath freshening consumable film
JP2005013375A (en) 2003-06-25 2005-01-20 Pentel Corp Brush with built-in liquid chemical
US20060062910A1 (en) * 2004-03-01 2006-03-23 Meiere Scott H Low zirconium, hafnium-containing compositions, processes for the preparation thereof and methods of use thereof
CN101426530B (en) 2004-05-12 2012-03-07 梅迪沃什有限公司 Wound healing polymer compositions and methods for use thereof
EP1604693A1 (en) * 2004-06-09 2005-12-14 Scil Technology GmbH In situ forming scaffold, its manufacturing and use
US20050281757A1 (en) 2004-06-17 2005-12-22 Sayed Ibrahim Oral care film
US20060115785A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US20060140881A1 (en) 2004-12-22 2006-06-29 Guofeng Xu Oral care compositions containing flavonoids and flavans
US20060292092A1 (en) * 2005-06-22 2006-12-28 Deepak Sharma Oral care compositions, devices, and methods of using the same
EP1903905B1 (en) * 2005-07-12 2016-12-28 Colgate-Palmolive Company Oral care implement having reservoir for dispensing active agent
US8009680B2 (en) * 2005-07-29 2011-08-30 Nextel Communications Inc. System and method for a private wireless network interface
US20070181144A1 (en) * 2006-02-07 2007-08-09 Whitehill Oral Technologies, Inc. Coated dental devices with dry-to-the-touch, flavor-absorbing, saliva soluble coatings and methods for manufacturing
JP5066665B2 (en) 2006-05-23 2012-11-07 クラスターテクノロジー株式会社 Porous chitin-polyamide composite
US9682256B2 (en) 2006-07-14 2017-06-20 Colgate-Palmolive Company Methods of making compositions comprising films
US20080057103A1 (en) * 2006-08-21 2008-03-06 Wouter Roorda Methods of using medical devices for controlled drug release
US8075216B2 (en) * 2007-01-25 2011-12-13 Colgate-Palmolive Company Oral care implement housing an oral care agent
US20080235763A1 (en) * 2007-03-20 2008-09-25 At&T Knowledge Ventures, Lp System and method of providing security for a multimedia timeline
US8250190B2 (en) * 2007-03-29 2012-08-21 At&T Intellectual Property I, L.P. Systems and methods for retrieving customer premise equipment data
US20080285545A1 (en) * 2007-05-14 2008-11-20 Broadcom Corporation Voice over ip customer premises equipment

Also Published As

Publication number Publication date
RU2010137327A (en) 2012-03-20
EP2252254A4 (en) 2014-01-08
JP2011512335A (en) 2011-04-21
BRPI0906452A2 (en) 2015-07-14
RU2519329C2 (en) 2014-06-10
AU2009212331A1 (en) 2009-08-13
AR070695A1 (en) 2010-04-28
US20100322986A1 (en) 2010-12-23
CA2706512C (en) 2013-12-24
CO6290716A2 (en) 2011-06-20
US10130597B2 (en) 2018-11-20
CN101938985A (en) 2011-01-05
MY155410A (en) 2015-10-15
TWI367763B (en) 2012-07-11
WO2009100275A2 (en) 2009-08-13
CA2706512A1 (en) 2009-08-13
AU2009212331B2 (en) 2011-12-08
EP2252254A2 (en) 2010-11-24
CN105030558A (en) 2015-11-11
ZA201003685B (en) 2015-06-24
EP2252254B1 (en) 2018-08-08
WO2009100275A3 (en) 2009-12-03
MX2010005004A (en) 2010-05-27

Similar Documents

Publication Publication Date Title
TW201006503A (en) Compositions and devices
TWI355278B (en) Non-aqueous liquid tooth whitening composition
RU2441641C1 (en) Compositions and means of cleaning
AU2006202662A1 (en) Oral care compositions, devices, and methods of using the same
TWI290049B (en) Hydrophobic tooth whitening system and methods of use
US20060292090A1 (en) Oral care compositions, devices, and methods of using the same
TW200522977A (en) Silicone polymer based liquid tooth whitening composition
TW201002273A (en) Dental wipe
US20090317339A1 (en) Teeth Bleaching Compositions and Devices
TWI376237B (en) Tooth sealant
TW201538175A (en) Oral care compositions and methods
JP2008303188A (en) Candida biofilm eliminating agent
EP2056787B2 (en) Denture care composition
TW201532622A (en) Oral care compositions and methods
JP2012509271A (en) Dental instrument cleanser
EP2700396A2 (en) Strip for the delivery of oral care compositions
US20040170577A1 (en) Aqueous slurries useful for cleaning teeth and methods related thereto
RU2533226C1 (en) Oral and dental care wipe
MX2015007789A (en) Oral care composition containing ionic liquids.
Gojanur OZONE THERAPY-AN ALTERNATIVE TO CONVENTIONAL THERAPY IN PEDIATRIC DENTISTRY.
JPH11240816A (en) Composition for coating tooth
Joshi et al. OZONE IN PEDIATRIC DENTISTRY-A REVIEW
Ciancio Dental products
JP2007297383A (en) Method for whitening tooth

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees